Jack Hirsh - McMaster Experts

Affiliations

Faculty of Health Sciences, McMaster University
Associate Member, Health Research Methods, Evidence, and Impact, Faculty of Health Sciences
Professor Emeritus, Medicine, Faculty of Health Sciences

Scholarly Activity in McMaster Experts

Co-author Network

Scholarly Activity
Contact
View All

selected scholarly activity

chapters
- Antithrombotic Therapy. 171-177. 2012
- Pathogenesis of venous thromboembolism. 39-56. 2003
conferences
- Bleeding in Patients with Atrial Fibrillation Treated with Different Doses of Direct Oral Anticoagulants and Vitamin K Antagonists: A Population-Based Study. Blood. 2617-2617. 2016
- Bleeding in Patients with Atrial Fibrillation Treated with Non Vitamin K Antagonist Oral Anticoagulants: A Population-Based Study. Blood. 343-343. 2014
- Evaluation of the Venowave (Venous-Return Assist Device) on walking distance in peripheral arterial disease. Vascular Medicine. 155-156. 2013
- 504 Subtle Differences in Commercial Heparins Can Have Serious Consequences for Cardiopulmonary Bypass Patients: a randomized controlled trial. Canadian Journal of Cardiology. S285-S285. 2012
- Impact of the Modified Henry Ford Warfarin Maintenance Dosing Algorithm an Quality of Anticoagulation at a Specialist Anticoagulation Clinic. Circulation. S1150-S1150. 2009
- Anticoagulant intensity of enoxaparin compared with fondaparinux in the OASIS-5 trial. European Heart Journal. 746-746. 2008
- Combined antiplatelet and anticoagulant therapy: clinical benefits and risks. Journal of Thrombosis and Haemostasis. 255-263. 2007
- Evaluation of a VENOus-Return assist device (Venowave (TM)) to treat severe post-thrombotic syndrome (VENOPTS): A randomized controlled trial.. Blood. 263A-263A. 2006
- Fixed-Dose, Weight-Adjusted, Unfractionated Heparin (UFH) Given Subcutaneously (sc) without Laboratory Monitoring for Acute Treatment of Venous Thromboembolism (VTE): Randomized Comparison with Low-Molecular-Weight-Heparin (LMWH).. Blood. 707-707. 2004
- Incidence of Recurrent Venous Thromboembolism According to Duration of Vitamin K Antagonists: Results of a Meta-Analysis on Individual Data.. Blood. 710-710. 2004
- Factors at baseline influencing the risk of recurrence in venous thromboembolism: Results of a meta-analysis on individual patient data.. Blood. 209A-209A. 2003
- Influence of age on the risk of recurrence in venous thromboembolism and on the risk of major hemorrhage during oral anticoagulant therapy: Results of a meta-analysis on individual patient data.. Blood. 56A-56A. 2003
- Current anticoagulant therapy—unmet clinical needs. Thrombosis Research. S1-S8. 2003
- A randomized trial of two intensities of warfarin (international normalized ratio of 2.0 to 3.0 versus 3.1 to 4.0) for the prevention of recurrent thrombosis in patients with antiphospholipid antibodies.. Blood. 148A-148A. 2002
- Effects of a novel venous-return assist device ("venowave") on lower limb venous flow in patients with post-thrombotic syndrome. Blood. 117B-117B. 2002
- GH9001, a novel antithrombotic agent, is more effective than low-molecular-weight heparin or hirudin in rabbit models.. Blood. 83A-83A. 2002
- Reduction of out-of-hospital symptomatic venous thromboembolism by extended thromboprophylaxis with low molecular weight heparin following elective hip arthroplasty. A systematic review.. Blood. 703A-703A. 2002
- Four weeks versus 12 weeks of anticoagulation for a first episode of venous thromboembolism (VTE) provoked by a transient-risk factor: A randomized double-blind trial.. Blood. 448A-448A. 2001
- In vitro comparison of the effect of heparin, low-molecular-weight heparin and pentasaccharide on tests of coagulation.. Blood. 45A-45A. 2001
- New anticoagulants. American Heart Journal. S3-S8. 2001
- Developing a novel antithrombotic in the academic environment. Seminars in Hematology. 4-11. 2001
- Treatment of excessive anticoagulation due to warfarin with oral vitamin K: A randomized controlled trial.. Blood. 450A-450A. 2000
- Randomized comparison of vasoflux, a novel anticoagulant, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction. European Heart Journal. 187-187. 2000
- Use of antithrombotic agents during pregnancy. Annales de Cardiologie et d'Angeiologie. 81-83. 2000
- Simplifying heparin monitoring.. Blood. 26A-27A. 1999
- Subcutaneous and oral direct thrombin inhibitors for prophylaxis of deep venous thrombosis and pulmonary embolism after total hip and knee replacement.. Blood. 589A-589A. 1999
- Extended out-of-hospital LMWH venous thromboembolism prophylaxis after total hip or knee replacement surgery.. Blood. 500A-500A. 1998
- Heparin-induced bone loss is not reversible after stopping heparin treatment in rats.. Blood. 358A-358A. 1998
- The effect of heparin and low molecular weight heparin on osteoblastogenesis in vitro.. Blood. 358A-358A. 1998
- Randomized comparison of moderate (INR 3.0-3.5) with low intensity (INR 2.0-3.5) anticoagulant therapy in patients with prosthetic heart valves treated with aspirin (100 mg/day).. Circulation. 768-768. 1998
- V20, a glycoprotein IIb/IIIa-independent inhibitor of platelet-dependent clotting reactions, inhibits both arterial and venous-type thrombosis in primates. Circulation. 800-800. 1998
- Low-molecular-weight heparin for the treatment of venous thromboembolism. American Heart Journal. S336-S342. 1998
- The Incidence of Symptomatic Venous Thromboembolism During and After Prophylaxis With Enoxaparin<subtitle>A Multi-institutional Cohort Study of Patients Who Underwent Hip or Knee Arthroplasty</subtitle>. JAMA Internal Medicine. 873-873. 1998
- The clinical pharmacology of Vasoflux (TM) compared to heparin, results of a phase I clinical trial. XIII WORLD CONGRESS OF CARDIOLOGY. 1045-1049. 1998
- The value of bilateral venous compression ultrasonography in patients with suspected pulmonary embolism (PE).. Blood. 1303-1303. 1997
- Vasoflux, a novel anticoagulant that is more effective than heparin and safer than hirudin in rabbits.. Blood. 1316-1316. 1997
- Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis. Seminars in Hematology. 20-25. 1997
- A novel antithrombin-heparin covalent complex: Efficacy and safety in rabbits. Thrombosis and Haemostasis. P2812-P2812. 1997
- A randomized comparison of a 5 mg and 10 mg loading dose for the initiation of warfarin therapy. Thrombosis and Haemostasis. O2382-O2382. 1997
- Evidence that vitronectin contributes to non-specific binding of heparin in patient plasma. Thrombosis and Haemostasis. P1222-P1222. 1997
- Low-dose oral vitamin K for the reversal of warfarin associated coagulopathy. Blood. 699-699. 1996
- Double blind comparison of aspirin with warfarin following bioprosthetic heart valve replacement.. Circulation. 3802-3802. 1996
- Comparison Of The Relative Efficacy And Safety Of Low Molecular Weight Heparin And Unfractionated Heparin For The Treatment Of Venous Thrombosis. Pathophysiology of Haemostasis and Thrombosis: international journal on haemostasis and thrombosis research. 189-198. 1996
- Activated protein C resistance is not associated with postoperative deep vein thrombosis in patients undergoing hip or knee surgery.. Blood. 2450-2450. 1995
- Administration of no-affinity heparin (NAH) in vivo alters the tissue localisation and metabolism of unfractionated heparin (UFH).. Blood. 3510-3510. 1995
- Altered recovery but not clearance contributes to the variation in anticoagulant response to heparin in vivo.. Blood. 3511-3511. 1995
- Formation of heparin-induced thrombocytopenia IgG (HIT-IgG) without thrombocytopenia: Analysis of a clinical trial.. Blood. 2137-2137. 1995
- EFFECTS OF ORAL ANTICOAGULANTS ON MORTALITY, REINFARCTION AND STROKE AFTER MYOCARDIAL-INFARCTION. Circulation. 1632-1632. 1995
- Aspirin and Other Platelet-Active Drugs. Chest. 247S-257S. 1995
- Hemorrhagic Complications of Thrombolytic Therapy in the Treatment of Myocardial Infarction and Venous Thromboembolism. Chest. 291S-301S. 1995
- NEW ANTITHROMBOTICS. Chest. S471-S485. 1995
- Use of Antithrombotic Agents During Pregnancy. Chest. 305S-311S. 1995
- HIRUDIN, BUT NOT HEPARIN, ACCELERATES PHYSIOLOGICAL FIBRINOLYSIS IN A RABBIT CHRONIC VENOUS THROMBOSIS MODEL. Thrombosis and Haemostasis. 1454-1454. 1995
- MULTICENTRIC EVALUATION OF HEPARINASE ON APTT, THROMBIN CLOTTING TIME AND A NEW PT REAGENT BASED ON RECOMBINANT HUMAN TISSUE FACTOR. Thrombosis and Haemostasis. 1113-1113. 1995
- OUT PATIENT LOW-MOLECULAR-WEIGHT HEPARIN VERSUS IN-HOSPITAL STANDARD HEPARIN FOR THE TREATMENT OF VENOUS THROMBOSIS. Thrombosis and Haemostasis. 1092-1092. 1995
- THE EFFECT OF ANTITHROMBIN-III AND HEPARIN COFACTOR-II CONCENTRATIONS ON THE ANTICOAGULANT ACTIVITIES OF STANDARD AND LOW-MOLECULAR-WEIGHT HEPARIN IN PLASMA. Thrombosis and Haemostasis. 935-935. 1995
- THE EFFECT OF HEPARIN-BINDING PROTEINS ON THE ANTI-THROMBIN ACTIVITY OF UNFRACTIONATED AND LOW-MOLECULAR-WEIGHT HEPARIN IN PLASMA. Thrombosis and Haemostasis. 973-973. 1995
- TREATMENT OF DEEP VENOUS THROMBOSIS WITH LOW-MOLECULAR-WEIGHT HEPARINS - A METAANALYSIS. Thrombosis and Haemostasis. 1106-1106. 1995
- Low Molecular Weight Heparins (LMWH) in the Treatment of Patients with Acute Venous Thromboembolism. Thrombosis and Haemostasis. 360-363. 1995
- A PROSPECTIVE-STUDY OF HEPARIN-INDUCED THROMBOCYTOPENIA - UNFRACTIONATED HEPARIN COMPARED WITH LOW-MOLECULAR-WEIGHT HEPARIN. Blood. A188-A188. 1994
- ABNORMALITIES IN FIBRINOLYSIS PREDICT FOR RECURRENT DEEP-VEIN THROMBOSIS. Blood. A69-A69. 1994
- A CRITICAL ANALYSIS OF THE ACCURACY OF ULTRASOUND (US) FOR THE DIAGNOSIS OF DEEP-VEIN THROMBOSIS (DVT) IN ASYMPTOMATIC POSTOPERATIVE-PATIENTS. Blood. A407-A407. 1993
- LOW-MOLECULAR-WEIGHT HEPARINS SHOW PROLONGED ANTI-IIA PLASMA HALF-LIFE. Circulation. 224-224. 1993
- THE LIMITATIONS OF HEPARIN AND POTENTIAL ADVANTAGES OF NEW ANTICOAGULANTS. Circulation. C-D. 1993
- A COMPARISON OF THE PLASMA RECOVERY OF UNFRACTIONATED HEPARIN WITH THAT OF DERMATAN SULFATE IN PATIENTS WITH THROMBOEMBOLIC DISEASE. Thrombosis and Haemostasis. 657-657. 1993
- A DOUBLE-BLIND RANDOMIZED TRIAL OF MINI-DOSE WARFARIN FOR THE PREVENTION OF THROMBOEMBOLISM (TE) IN PATIENTS WITH STAGE-IV BREAST-CANCER. Thrombosis and Haemostasis. 981-981. 1993
- A RANDOMIZED TRIAL COMPARING THE ACTIVATED THROMBOPLASTIN TIME WITH THE HEPARIN ASSAY TO MONITOR HEPARIN-THERAPY IN PATIENTS WITH ACUTE VENOUS THROMBOEMBOLISM REQUIRING LARGE DAILY DOSES OF HEPARIN. Thrombosis and Haemostasis. 1122-1122. 1993
- A RANDOMIZED, DOUBLE-BLIND TRIAL COMPARING A LOW-MOLECULAR-WEIGHT HEPARINOID, ORGARAN, WITH ASPIRIN IN THE PREVENTION OF VENOUS THROMBOEMBOLISM FOLLOWING SURGERY FOR HIP FRACTURE. Thrombosis and Haemostasis. 1116-1116. 1993
- COMPARISON OF THE EFFICACY AND COST OF LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) AND STANDARD HEPARIN (SH) FOR THE PREVENTION OF DEEP-VEIN THROMBOSIS (DVT) FOLLOWING TOTAL HIP-REPLACEMENT (THR). Thrombosis and Haemostasis. 650-650. 1993
- DETERMINANTS OF THE ANTITHROMBOTIC RESPONSE TO A STANDARDIZED DOSE OF INTRAVENOUS UNFRACTIONATED HEPARIN IN PATIENTS WITH VENOUS THROMBOEMBOLISM. Thrombosis and Haemostasis. 768-768. 1993
- EVALUATION OF THE ACCURACY OF IMPEDANCE PLETHYSMOGRAPHY (IPG) AND COMPRESSION ULTRASOUND (CUS) IN OUTPATIENTS WITH SUSPECTED DEEP-VEIN THROMBOSIS (DVT) - A PROSPECTIVE PAIRED DESIGN. Thrombosis and Haemostasis. 1355-1355. 1993
- EX-VIVO COMPARISON OF THE NONSPECIFIC-BINDING OF UNFRACTIONATED HEPARIN AND ENOXAPARIN TO PLASMA-PROTEINS. Thrombosis and Haemostasis. 857-857. 1993
- HEPARIN VARIABILITY AND RESISTANCE - COMPARISONS WITH A DIRECT THROMBIN INHIBITOR. Thrombosis and Haemostasis. 1300-1300. 1993
- OPTIMAL DURATION OF ORAL ANTICOAGULANT-THERAPY - A RANDOMIZED TRIAL COMPARING 4 WEEKS WITH 3 MONTHS OF WARFARIN IN PATIENTS WITH PROXIMAL DEEP-VEIN THROMBOSIS (DVT). Thrombosis and Haemostasis. 982-982. 1993
- PLASMA HALF-LIFE OF THE ANTI-IIA ACTIVITY OF LOW-MOLECULAR-WEIGHT HEPARINS ASSESSED WITH A SENSITIVE TEST (PTNA). Thrombosis and Haemostasis. 768-768. 1993
- THE COMBINATION OF PRETEST CLINICAL LIKELIHOOD (PCL) AND NONINVASIVE TESTS IMPROVES MANAGEMENT OF OUTPATIENTS WITH SUSPECTED DEEP-VEIN THROMBOSIS (DVT). Thrombosis and Haemostasis. 1080-1080. 1993
- THE RECOVERY OF HEPARIN AND HIRUDIN FROM THE PLASMA OF HEPARIN-RESISTANT PATIENTS. Thrombosis and Haemostasis. 659-659. 1993
- WARFARIN AND ITS DRUG FOOD INTERACTIONS - A CRITICAL-APPRAISAL OF THE LITERATURE. Thrombosis and Haemostasis. 1133-1133. 1993
- A simplified procedure for the establishment of APTT therapeutic ranges for heparin (HEP) therapy. Thrombosis and Haemostasis. 652-652. 1993
- PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM. THROMBOSIS AND ITS MANAGEMENT. 159-181. 1993
- PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM IN THE ELDERLY. International Congress Series. 625-635. 1993
- SUSTAINED ANTITHROMBOTIC ACTIVITY OF HIRUDIN AFTER ITS PLASMA-CLEARANCE - COMPARISON WITH HEPARIN. Thrombosis Research. S16-S16. 1993
- A PHASE-II STUDY OF HIRULOG IN THE PREVENTION OF VENOUS THROMBOSIS AFTER MAJOR HIP OR KNEE SURGERY. Circulation. 409-409. 1992
- APTTS AFTER THROMBOLYSIS AND STANDARD INTRAVENOUS HEPARIN ARE OFTEN LOW AND CORRELATE WITH BODY-WEIGHT, AGE AND SEX - EXPERIENCE FROM THE GUSTO TRIAL. Circulation. 258-258. 1992
- HEPARIN BINDING-PROTEINS - POSSIBLE CAUSE OF HEPARIN REBOUND FOLLOWING CARDIOPULMONARY BYPASS. Circulation. 630-630. 1992
- REDUCED BINDING OF LOW-MOLECULAR-WEIGHT HEPARINS TO PLASMA-PROTEINS. Circulation. 869-869. 1992
- THE EFFECT OF PLASMA-PROTEINS ON THE ANTI-IIA AND ANTI-XA ACTIVITIES OF STANDARD HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN. Circulation. 869-869. 1992
- LOW-MOLECULAR-WEIGHT HEPARIN IN THE TREATMENT AND PROPHYLAXIS OF THROMBOSIS. British Journal of Haematology. 191-193. 1992
- Relationship Between Dose, Anticoagulant Effect and the Clinical Efficacy and Safety of Heparin. Advances in Experimental Medicine and Biology. 283-295. 1992
- A DOUBLE-BLIND RANDOMIZED TRIAL OF ORG 10172 LOW-MOLECULAR-WEIGHT HEPARINOID VERSUS UNFRACTIONATED HEPARIN IN THE PREVENTION OF DEEP-VEIN THROMBOSIS IN PATIENTS WITH THROMBOTIC STROKE. Thrombosis and Haemostasis. 753-753. 1991
- ANTITHROMBIN-III INDEPENDENT THROMBIN INHIBITORS PREVENT THROMBUS GROWTH MORE EFFECTIVELY THAN HEPARIN - IMPLICATIONS FOR ANTITHROMBOTIC THERAPY. Thrombosis and Haemostasis. 829-829. 1991
- COMPARISON OF ANTITHROMBIN ACTIVITIES OF HEPARIN AND HIRULOG-1 - BASIS FOR IMPROVED ANTITHROMBOTIC PROPERTIES OF DIRECT THROMBIN INHIBITORS. Thrombosis and Haemostasis. 829-829. 1991
- DEEP VENOUS THROMBOSIS - NEW NONINVASIVE DIAGNOSTIC-TESTS. Thrombosis and Haemostasis. 784-784. 1991
- EVIDENCE FOR THE PROLONGED CLEARANCE OF ANTI-THROMBIN ACTIVITY OF THE LOW-MOLECULAR-WEIGHT HEPARIN ENOXAPRINE. Thrombosis and Haemostasis. 1298-1298. 1991
- GLYCOSAMINOGLYCANS DISPLACE ANTICOAGULANTLY-ACTIVE HEPARIN FROM PLASMA-PROTEIN BINDING-SITES. Thrombosis and Haemostasis. 933-933. 1991
- IMPAIRED FIBRINOLYTIC-ACTIVITY AND RECURRENT VENOUS THROMBOEMBOLIC DISEASE. Thrombosis and Haemostasis. 979-979. 1991
- SUSTAINED ANTITHROMBOTIC ACTIVITY AFTER PLASMA-CLEARANCE OF HIRUDIN - COMPARISON WITH HEPARIN. Thrombosis and Haemostasis. 651-651. 1991
- TEFLON CATHETER USE FOR SUBCUTANEOUS HEPARIN ADMINISTRATION DURING PREGNANCY - A RANDOMIZED CROSSOVER STUDY. Thrombosis and Haemostasis. 924-924. 1991
- Rationale for development of low-molecular-weight heparins and their clinical potential in the prevention of postoperative venous thrombosis. American Journal of Surgery. 512-518. 1991
- Comparative effects of heparin and LMW heparin on hemostasis. Thrombosis Research. 11-17. 1991
- A HEPARIN NOMOGRAM FOR THE MANAGEMENT OF HEPARIN-THERAPY IN VENOUS THROMBOSIS. Circulation. 604-604. 1990
- A HEPARIN NOMOGRAM FOR THE MANAGEMENT OF HEPARIN-THERAPY IN VENOUS THROMBOSIS. Arteriosclerosis. A912-A912. 1990
- THE EFFECTS OF A FREE FATTY-ACID (FFA) PREPARATION OF OMEGA-3 POLYUNSATURATED FATTY-ACIDS (PUFA) ON PLATELET-FUNCTION ALONE AND IN COMBINATION WITH ASA AND LOW-MOLECULAR-WEIGHT HEPARIN (LMWH). Arteriosclerosis. A941-A941. 1990
- THE EFFECT OF STORAGE ON PLASMA SAMPLES USED IN HEPARIN ASSAYS. Clinical Chemistry. 975-976. 1990
- DIAGNOSIS OF DEEP VENOUS THROMBOSIS - PLATELET SCINTIGRAPHY, COLOR AND DUPLEX DOPPLER-US, AND IMPEDANCE PLETHYSMOGRAPHY VERSUS VENOGRAPHY. Radiology. 1075-1075. 1990
- Diagnosis of venous thrombosis and pulmonary embolism. American Journal of Cardiology. C45-C49. 1990
- Comparison of platelet scintigraphy, impedance plethysmography gray scale and color flow duplex ultrasound and venography for the diagnosis of venous thrombosis.. Progress in Clinical and Biological Research. 23-27. 1990
- Prevention of venous thrombosis in patients undergoing major orthopaedic surgical procedures.. British Journal of Surgery. 30-35. 1990
- THE DEVELOPMENT OF LMW HEPARINS FOR CLINICAL USE - BIOCHEMICAL, EXPERIMENTAL, AND CLINICAL FINDINGS. PROTEIN C AND RELATED ANTICOAGULANTS. 67-82. 1990
- OPTIMAL THERAPEUTIC RANGE FOR ORAL ANTICOAGULANT-THERAPY. Thrombosis and Haemostasis. 315-315. 1989
- RELATIONSHIP BETWEEN ANTI-FACTOR-XA LEVEL AND CLINICAL OUTCOME IN PATIENTS RECEIVING ENOXAPARINE TO PREVENT DEEP-VEIN THROMBOSIS AFTER HIP-REPLACEMENT. Thrombosis and Haemostasis. 520-520. 1989
- THROMBOLYTIC THERAPY FOR VENOUS THROMBOSIS AND PULMONARY-EMBOLISM. Thrombosis and Haemostasis. 547-547. 1989
- EFFECTS OF DERMATAN SULFATE AND HEPARIN ON INHIBITION OF THROMBUS GROWTH-INVIVO. HEPARIN AND RELATED POLYSACCHARIDES : STRUCTURE AND ACTIVITIES. 304-312. 1989
- HEPARIN-THERAPY IN VENOUS THROMBOEMBOLISM. HEPARIN AND RELATED POLYSACCHARIDES : STRUCTURE AND ACTIVITIES. 378-385. 1989
- A RANDOMIZED TRIAL COMPARING GRADUATED COMPRESSION STOCKINGS ALONE OR GRADUATED COMPRESSION STOCKINGS PLUS INTERMITTENT PNEUMATIC COMPRESSION WITH CONTROL IN THE PREVENTION OF DEEP-VEIN THROMBOSIS IN NEUROSURGICAL PATIENTS. Arteriosclerosis. A675-A675. 1988
- THE OPTIMAL THERAPEUTIC RANGE FOR THE CONTROL OF ORAL ANTICOAGULANTS. Australian and New Zealand Journal of Medicine. 428-428. 1988
- HEPARIN EFFECT ON BONE-DENSITY. Clinical Research. A410-A410. 1988
- HEPARIN-THERAPY IN PREGNANCY - EFFECTS ON THE FETUS. Clinical Research. A410-A410. 1988
- A DOUBLE-BLIND RANDOMIZED TRIAL OF ORG-10172 LOW-MOLECULAR-WEIGHT HEPARINOID IN THE PREVENTION OF DEEP-VEIN THROMBOSIS IN PATIENTS WITH THROMBOTIC STROKE. Thrombosis and Haemostasis. 123-123. 1987
- CANCER-CHEMOTHERAPY AND THROMBOSIS. Thrombosis and Haemostasis. 114-114. 1987
- DEEP-VEIN THROMBOSIS PROPHYLAXIS IN SURGICALLY TREATED FRACTURED HIP PATIENTS. Thrombosis and Haemostasis. 241-241. 1987
- HEPARIN IS NOT AN EFFICIENT INHIBITOR OF THE FACTOR XA-DEPENDENT ACTIVATION OF FACTOR-V AND FACTOR-VIII. Thrombosis and Haemostasis. 36-36. 1987
- UTILITY OF IMPEDANCE PLETHYSMOGRAPHY IN CHILDREN WITH CLINICALLY SUSPECTED VENOUS THROMBOEMBOLIC DISEASE. Pediatric Research. A307-A307. 1987
- CANCER-CHEMOTHERAPY AND THROMBOSIS. Breast Cancer Research and Treatment. 122-122. 1987
- DDAVP REDUCES THE PLATELET DEFECT ASSOCIATED WITH HEPARIN. Circulation. 95-95. 1986
- RANDOMIZED CONTROLLED TRIAL OF PK-10169 LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) FOR VENOUS THROMBOSIS PROPHYLAXIS AFTER ELECTIVE HIP-SURGERY. Circulation. 235-235. 1986
- A RANDOMIZED DOUBLE-BLIND TRIAL EVALUATING INTRAVENOUS HEPARIN-THERAPY FOR VENOUS THROMBOSIS - THE THERAPEUTIC RANGE. Clinical Research. A658-A658. 1986
- COMPARISON OF THE RATE OF ONSET, INTENSITY, AND DURATION OF THE ANTICOAGULANT EFFECT OF INTRAVENOUS AND SUBCUTANEOUS HEPARIN IN PATIENTS WITH VENOUS THROMBOSIS. Clinical Research. A638-A638. 1986
- A RANDOMIZED DOUBLE-BLIND TRIAL OF INTRAVENOUS VERSUS SUBCUTANEOUS HEPARIN IN THE INITIAL TREATMENT OF PROXIMAL-VEIN THROMBOSIS - THE THERAPEUTIC RESPONSE. Clinical and Investigative Medicine. B30-B30. 1986
- KINETICS OF INTRAVENOUS AND SUBCUTANEOUS HEPARIN IN THE INITIAL TREATMENT OF VENOUS THROMBOSIS. Clinical and Investigative Medicine. B30-B30. 1986
- THERAPEUTIC RANGE FOR CONTROL OF ORAL ANTICOAGULANT-THERAPY. Thrombosis Research. 68-68. 1986
- A DERMATAN SULFATE-LIKE ANTICOAGULANT IN THE FETAL LAMB AFTER ADMINISTRATION OF PK-10169 TO THE EWE. Thrombosis and Haemostasis. 32-32. 1985
- A RANDOMIZED TRIAL OF RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR FOR THE TREATMENT OF PROXIMAL DEEP-VEIN THROMBOSIS. Circulation. 193-193. 1985
- COMPARISON OF RESULTS OF HEPARIN ASSAYS IN PATIENTS WITH VENOUS THROMBOSIS TREATED WITH INTRAVENOUS HEPARIN MONITORED WITH THE APTT. Thrombosis and Haemostasis. 28-28. 1985
- DEVELOPMENT AND CLINICAL-EVALUATION OF AN AUTOMATED-ASSAY FOR EFFECTIVE HEPARIN ACTIVITY. Thrombosis and Haemostasis. 29-29. 1985
- HEMORRHAGIC COMPLICATIONS OF LONG-TERM ANTICOAGULANT-THERAPY. Thrombosis and Haemostasis. 294-294. 1985
- RATIONALE BEHIND THE DEVELOPMENT OF LOW-MOLECULAR WEIGHT HEPARIN DERIVATIVES. Thrombosis and Haemostasis. 308-308. 1985
- SYSTEMIC FIBRINOLYSIS IN VENOUS THROMBOSIS PATIENTS TREATED WITH RECOMBINANT TISSUE-TYPEPLASMINOGEN ACTIVATOR. Thrombosis and Haemostasis. 174-174. 1985
- TAILORING PROPHYLAXIS TO THE RISK OF THROMBOSIS AND BLEEDING. Thrombosis and Haemostasis. 280-280. 1985
- Logistics of double-blinding a randomized trial of intravenous vs. subcutaneous heparin for the treatment of venous thrombosis. Contemporary Clinical Trials. 300-300. 1984
- A MODEL FOR THE PHARMACOKINETICS OF STANDARD HEPARIN AND HEPARIN OF LOW-MOLECULAR WEIGHT. Nouvelle Revue Francaise d'Hematologie. 414-414. 1984
- ALTERED FETAL LAMB COAGULATION AFTER ADMINISTRATION OF LOW-MOLECULAR WEIGHT HEPARIN TO THE EWE. Circulation. 362-362. 1984
- EFFECTS OF LOW-MOLECULAR WEIGHT HEPARIN FRACTIONS ON INHIBITION OF THROMBUS GROWTH. Circulation. 361-361. 1984
- SUSTAINED THERAPEUTIC ANTICOAGULATION WITH SUBCUTANEOUS HEPARIN FOR THE PRIMARY-TREATMENT OF VENOUS THROMBOSIS. Clinical Pharmacology and Therapeutics. 268-268. 1984
- SUSTAINED THERAPEUTIC HEPARINIZATION BY SUBCUTANEOUS ADMINISTRATION FOR THE PRIMARY-TREATMENT OF ACUTE VENOUS THROMBOSIS. Circulation. 360-360. 1984
- A COST-EFFECTIVENESS ANALYSIS OF ALTERNATIVE APPROACHES FOR LONG-TERM TREATMENT OF PROXIMAL VENOUS THROMBOSIS. Thrombosis and Haemostasis. 66-66. 1983
- A RANDOMIZED TRIAL OF DIAGNOSTIC STRATEGIES FOR SYMPTOMATIC DEEP-VEIN THROMBOSIS. Thrombosis and Haemostasis. 160-160. 1983
- A RANDOMIZED TRIAL OF SEQUENTIAL PNEUMATIC LIMB COMPRESSION IN THE PREVENTION OF VENOUS THROMBOEMBOLISM FOLLOWING ELECTIVE HIP-SURGERY. Thrombosis and Haemostasis. 66-66. 1983
- A ROLE FOR LUNG-SCANNING EARLY IN THE MANAGEMENT OF PATIENTS WITH PROXIMAL DEEP VENOUS THROMBOSIS. Circulation. 267-267. 1983
- COMPARATIVE EFFECTS OF 2 LOW-MOLECULAR WEIGHT (LMW) HEPARINS, PREPARED BY DIFFERENT FRACTIONATION TECHNIQUES, IN ANIMAL EXPERIMENTAL-MODELS. Thrombosis and Haemostasis. 424-424. 1983
- DOPPLER ULTRASONOGRAPHY IN PATIENTS WITH CLINICALLY SUSPECTED DEEP-VEIN THROMBOSIS - IMPROVED SENSITIVITY BY INCLUSION OF POSTERIOR TIBIAL VEIN EXAMINATION SITE. Thrombosis and Haemostasis. 153-153. 1983
- EFFECTS OF ASPIRIN AND SALICYLATE ON PLATELET-FUNCTION. Thrombosis and Haemostasis. 101-101. 1983
- FAILURE OF SULOCTIDIL TO PREVENT DEEP VENOUS THROMBOSIS IN NEUROSURGICAL PATIENTS. Thrombosis and Haemostasis. 248-248. 1983
- LONG-TERM TREATMENT OF VENOUS THROMBOSIS WITH LESS INTENSE ANTICOAGULATION. Thrombosis and Haemostasis. 311-311. 1983
- LONG-TERM TREATMENT OF VENOUS THROMBOSIS WITH LESS INTENSE ANTICOAGULATION. Clinical Pharmacology and Therapeutics. 221-221. 1983
- LOW-MOLECULAR WEIGHT HEPARIN DOES NOT CROSS THE PLACENTA. Thrombosis and Haemostasis. 225-225. 1983
- OUTCOME OF ABNORMAL IMPEDANCE PLETHYSMOGRAPHY RESULTS IN PATIENTS WITH PROXIMAL VEIN-THROMBOSIS - FREQUENCY OF RETURN TO NORMAL. Thrombosis and Haemostasis. 152-152. 1983
- THE DISPARITY BETWEEN HEPARIN-INDUCED BLEEDING AND COAGULATION AND PLATELET TESTS. Thrombosis and Haemostasis. 55-55. 1983
- THE USE OF LONG-TERM OUTCOME TO VALIDATE DIAGNOSTIC APPROACHES TO PATIENTS WITH CLINICALLY SUSPECTED RECURRENT DEEP VENOUS THROMBOSIS. Clinical Research. A234-A234. 1983
- DIAGNOSIS OF VENOUS THROMBOSIS AND PULMONARY-EMBOLISM. Pathophysiology of Haemostasis and Thrombosis: international journal on haemostasis and thrombosis research. 96-96. 1982
- OBJECTIVE DIAGNOSIS OF ACUTE RECURRENT DEEP-VEIN THROMBOSIS BY COMBINED NON-INVASIVE TESTING AND VENOGRAPHY. Clinical Research. A504-A504. 1982
- THE ROLE OF ANTICOAGULANTS AND ANTI-PLATELET DRUGS IN CEREBROVASCULAR-DISEASE. Pathophysiology of Haemostasis and Thrombosis: international journal on haemostasis and thrombosis research. 174-174. 1982
- A RANDOMIZED CLINICAL-TRIAL OF TITRATED DOSE SUBCUTANEOUS HEPARIN VERSUS WARFARIN IN THE LONG-TERM TREATMENT OF PATIENTS WITH VENOUS THROMBOSIS. Thrombosis and Haemostasis. 93-93. 1981
- ALTERATIONS OF PLATELET MORPHOLOGY IN HUMAN ISCHEMIC-HEART-DISEASE AND IN AN ACUTE THROMBOSIS RABBIT MODEL. Thrombosis and Haemostasis. 433-433. 1981
- DIAGNOSIS OF DEEP-VEIN THROMBOSIS - THE CASE FOR NON-INVASIVE TESTING. Thrombosis and Haemostasis. 250-250. 1981
- RELATIVE CONTRIBUTIONS OF THROMBIN AND ANTITHROMBIN-III AFFINITIES OF HEPARIN FRACTIONS TO THE RATE OF INACTIVATION OF THROMBIN BY ANTITHROMBIN-III. Thrombosis and Haemostasis. 42-42. 1981
- RELATIVE EFFECTS OF STANDARD AND LOW-MOLECULAR WEIGHT HEPARINS ON THE THROMBIN-ANTITHROMBIN-III AND FACTOR XA-ANTITHROMBIN-III REACTION-RATES. Clinical Research. A331-A331. 1981
- SEX-RELATED DIFFERENCES IN ASPIRIN PHARMACOKINETICS FOLLOWING IV-INJECTION IN RABBITS. Thrombosis and Haemostasis. 49-49. 1981
- THE USE OF NON-INVASIVE TESTING AND VENOGRAPHY FOR THE DIAGNOSIS OF ACUTE RECURRENT DEEP-VEIN THROMBOSIS. Thrombosis and Haemostasis. 168-168. 1981
- The Effects Of Heparin On The Activation Of Factor X And Prothrombin In Antithrombin III-Depleted Plasma. Thrombosis and Haemostasis. 40-40. 1981
- The Influence Of Heparin, Phospholipid And Platelets On The Thrombin Or Factor Xa Inactivation By Antithrombin III. Thrombosis and Haemostasis. 118-118. 1981
- The Lack Of Relationship Between Anti-Xa Activity And Antithrombotic Activity Of Low Molecular Weight Heparin. Thrombosis and Haemostasis. 116-116. 1981
- A RANDOMIZED CLINICAL-TRIAL OF TITRATED DOSE SUBCUTANEOUS HEPARIN VERSUS COUMADIN IN THE SECONDARY PROPHYLAXIS OF PATIENTS WITH VENOUS THROMBOSIS. Clinical Research. A470-A470. 1980
- A RANDOMIZED TRIAL OF LONG-TERM TREATMENT IN PATIENTS WITH CALF VEIN-THROMBOSIS. Clinical Research. A769-A769. 1980
- A RANDOMIZED TRIAL OF TITRATED DOSE SUBCUTANEOUS (SC) HEPARIN VERSUS WARFARIN IN LONG-TERM TREATMENT OF PATIENTS WITH DEEP VENOUS THROMBOSIS (VT). Circulation. 338-338. 1980
- AN EVALUATION OF THE RADIOIMMUNOASSAY FOR FRAGMENT-E IN THE DIAGNOSIS OF VENOUS THROMBOSIS IN CLINICALLY SYMPTOMATIC PATIENTS. Circulation. 167-167. 1980
- CALF AND THIGH COMPRESSION TO PREVENT VENOUS THROMBOSIS (VT) IN INTRA-CRANICAL DISEASE (ICD). Circulation. 337-337. 1980
- PREVENTION OF THE DIAGNOSTIC SUSPICION BIAS IN RANDOMIZED TRIALS OF LONG-TERM TREATMENTS OF VENOUS THROMBOSIS. Clinical Research. A474-A474. 1980
- REPLACEMENT OF VENOGRAPHY IN SUSPECTED VENOUS THROMBOSIS BY IMPEDANCE PLETHYSMOGRAPHY AND FIBRINOGEN-I-125 LEG SCANNING. Circulation. 336-336. 1980
- REVERSIBLE INHIBITION OF THE INTRINSIC PATHWAY ACTIVATION OF FACTOR-X BY HEPARIN IN THE ABSENCE OF ANTI-THROMBIN-III. The FASEB Journal. 544-544. 1980
- SEX-RELATED DIFFERENCES IN PLATELET-FUNCTION INVIVO FOLLOWING ASPIRIN ADMINISTRATION. Circulation. 342-342. 1980
- SEX-RELATED DIFFERENCES IN THE EFFECTS OF ASPIRIN ON HEMOSTATIC PLUG FORMATION INVIVO. Clinical Research. A315-A315. 1980
- THE INHIBITORY EFFECT OF ASPIRIN ON PLATELET-FUNCTION INDEPENDENT OF ACETYLATION OF CYCLO OXYGENASE. Circulation. 108-108. 1980
- THE RELATIONSHIP BETWEEN THE HEMORRHAGIC AND ANTI-THROMBOTIC EFFECTS OF STANDARD AND LOW-MOLECULAR WEIGHT (LMW) HEPARINS. Circulation. 51-51. 1980
- COMPARATIVE EFFECTS OF SODIUM AND CALCIUM HEPARIN ON PLASMA HEPARIN CONCENTRATION, PARTIAL THROMBOPLASTIN TIME, PLATELET COUNT AND BLEEDING. Circulation. 206-206. 1978
- COMPARATIVE-STUDY OF DOPPLER ULTRASOUND (DP) AND IMPEDANCE PLETHYSMOGRAPHY (IPG) IN DIAGNOSIS OF SYMPTOMATIC AND ASYMPTOMATIC DEEP-VEIN THROMBOSIS (DVT). Circulation. 117-117. 1978
- EFFECTIVENESS OF PULSATILE STOCKINGS FOR PREVENTION OF VENOUS THROMBOSIS AFTER ELECTIVE KNEE SURGERY. Circulation. 117-117. 1978
- THROMBOGENIC EFFECT OF HIGH DOSE ASPIRIN IN INJURY INDUCED EXPERIMENTAL VENOUS THROMBOSIS. Clinical Research. A350-A350. 1978
- EFFECT OF ASPIRIN ON DIPYRIDAMOLE PLASMA-LEVEL, DISTRIBUTION AND CLEARANCE. Blood. 260-260. 1977
- FIBRINOPEPTIDE-A (FPA) LEVELS IN VENOUS THROMBOSIS AND PULMONARY-EMBOLISM BEFORE AND DURING ANTICOAGULANT THERAPY. Thrombosis and Haemostasis. 74-74. 1977
- INCREASED HEPARIN CLEARANCE IN EXPERIMENTAL PULMONARY-EMBOLISM. Thrombosis and Haemostasis. 86-86. 1977
- LOW-DOSE HEPARIN PROPHYLAXIS - EFFICACY WITH OMISSION PREOPERATIVE DOSE. Blood. 279-279. 1977
- PREVENTION OF VENOUS THROMBOSIS BY INTERMITTENT CALF COMPRESSION IN PATIENTS WITH STROKES OR AFTER NEUROSURGERY. Circulation. 118-118. 1977
- The Biphasic Effect of Sulfinpyrazone on Platelet Function. Thrombosis and Haemostasis. 66-66. 1977
- The Effect of a Combination of Sulfinpyrazone (SUL) & Aspirin (ASA) on Platelet Survival & Thrombus Size in an Experimental Thrombosis Model. Thrombosis and Haemostasis. 140-140. 1977
- Vasoactive Substances in Pulmonary Embolism. Thrombosis and Haemostasis. 167-167. 1977
- ACCURACY OF 125 I-FIBRINOGEN LEG SCANNING FOR DETECTION OF POPLITEAL AND FEMORAL VEIN-THROMBOSIS. European Journal of Clinical Investigation. 320-320. 1976
- DEVELOPMENT OF ANTI-HEPARIN ACTIVITY IN STORED VACUTAINER TUBES. Blood. 1004-1004. 1976
- IMPEDANCE PLETHYSMOGRAPHY (IPG) AND FIBRINOGEN-I-125 LEG SCANNING (LEG-SCAN) IN DIAGNOSIS OF CLINICALLY SUSPECTED DEEP VENOUS THROMBOSIS (DVT). Circulation. 123-123. 1976
- RELATIONSHIP BETWEEN POSTOPERATIVE PULMONARY-EMBOLISM (PE) AND DEEP VENOUS THROMBOSIS (DVT). Circulation. 124-124. 1976
journal articles
- FRAIL-AF Study: More Bleeding With DOACs Compared With VKAs in Patients With Frailty?. Canadian Journal of Cardiology. 40:1377-1378. 2024
- The historical origins of modern international normalized ratio targets. Journal of Thrombosis and Haemostasis. 22:2184-2194. 2024
- Dosing Intensity of Anticoagulants for the Prevention and Treatment of Venous Thromboembolism and the Prevention of Stroke in Atrial Fibrillation: Why is There a Difference?. Seminars in Vascular Medicine. 2024
- Human papilloma virus and atherosclerotic cardiovascular disease. European Heart Journal. 45:1083-1085. 2024
- Unresolved issues in the use of direct acting oral anticoagulants. Expert Review of Cardiovascular Therapy. 21:913-921. 2023
- Clinical Studies with Anticoagulants that Have Changed Clinical Practice. Seminars in Vascular Medicine. 49:242-254. 2023
- Inflammation as a Mechanism and Therapeutic Target in Peripheral Artery Disease. Canadian Journal of Cardiology. 38:588-600. 2022
- Letter by de Vries et al Regarding Article “Off-Label Under- and Overdosing of Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Meta-Analysis”. Circulation. Cardiovascular Quality and Outcomes. 15:e008982. 2022
- Heparin-induced thrombocytopenia. CANADIAN MEDICAL ASSOCIATION JOURNAL. 193:E736-E736. 2021
- Mortality Benefit in the Compass Trial: is It Related to Superior Statistical Power Or Better Efficacy and safety?. Future Cardiology. 17:175-182. 2021
- Peripheral Oxygen Saturation in Older Persons Wearing Nonmedical Face Masks in Community Settings. Journal of the American Medical Association (JAMA). 324:2323-2323. 2020
- Plasma Apixaban Levels in Patients Treated Off Label With the Lower Dose. Journal of the American College of Cardiology. 76:2906-2907. 2020
- Apixaban for Stroke Prevention in Atrial Fibrillation: Why are Event Rates Higher in Clinical Practice than in Randomized Trials?—A Systematic Review. Thrombosis and Haemostasis. 120:1323-1329. 2020
- Fifty years of research on antithrombotic therapy: Achievements and disappointments. European Journal of Internal Medicine. 70:1-7. 2019
- Reduction in Mortality following Elective Major Hip and Knee Surgery: A Systematic Review and Meta-Analysis. Thrombosis and Haemostasis. 119:668-674. 2019
- In Vitro Reversal of the Anti-Aggregant Effect of Ticagrelor Using Untreated Platelets. Thrombosis and Haemostasis. 118:1895-1901. 2018
- Impact of cost on use of non-vitamin K antagonists in atrial fibrillation patients in Ontario, Canada. Journal of Thrombosis and Thrombolysis. 46:310-315. 2018
- Quantifying immature platelets as markers of increased platelet production after coronary artery bypass grafting surgery. European Journal of Haematology. 101:362-367. 2018
- Edoxaban for the Treatment of Venous Thromboembolism in Patients with Cancer. New England Journal of Medicine. 378:673-674. 2018
- The development and validation of an instrument to measure the quality of health research reports in the lay media. BMC Public Health. 17:343. 2017
- Laboratory Monitoring of Non–Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation. JAMA cardiology. 2:566-566. 2017
- Once versus twice daily aspirin after coronary bypass surgery: a randomized trial. Journal of Thrombosis and Haemostasis. 15:889-896. 2017
- Effect of Short-Term vs. Long-Term Blood Storage on Mortality after Transfusion. New England Journal of Medicine. 375:1937-1945. 2016
- Bleeding in patients with atrial fibrillation treated with dabigatran, rivaroxaban or warfarin: A retrospective population-based cohort study. European Journal of Internal Medicine. 33:55-59. 2016
- Rationale and Design of the Informing Fresh versus Old Red Cell Management (INFORM) Trial: An International Pragmatic Randomized Trial. Transfusion Medicine Reviews. 30:25-29. 2016
- Correction to Dosage in: Antiplatelet Drugs: Antithrombotic Therapy and Prevention of Thrombosis: 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 148:1529-1529. 2015
- Timing the First Postoperative Dose of Anticoagulants. Chest. 148:587-595. 2015
- A systematic review of contemporary trials of anticoagulants in orthopaedic thromboprophylaxis: suggestions for a radical reappraisal. Journal of Thrombosis and Thrombolysis. 40:231-239. 2015
- Medical device‐induced thrombosis: what causes it and how can we prevent it?. Journal of Thrombosis and Haemostasis. 13:S72-S81. 2015
- Real-world variability in dabigatran levels in patients with atrial fibrillation: reply. Journal of Thrombosis and Haemostasis. 13:1168-1169. 2015
- Active metabolite concentration of clopidogrel in patients taking different doses of aspirin: results of the interaction trial. Journal of Thrombosis and Haemostasis. 13:347-352. 2015
- Multiple daily doses of acetyl‐salicylic acid (ASA) overcome reduced platelet response to once‐daily ASA after coronary artery bypass graft surgery: a pilot randomized controlled trial. Journal of Thrombosis and Haemostasis. 13:448-456. 2015
- Real‐world variability in dabigatran levels in patients with atrial fibrillation. Journal of Thrombosis and Haemostasis. 13:353-359. 2015
- Lack of consistency in the relationship between asymptomatic DVT detected by venography and symptomatic VTE in thromboprophylaxis trials. Thrombosis and Haemostasis. 114:1049-1057. 2015
- Comparison of the effects of apixaban and rivaroxaban on prothrombin and activated partial thromboplastin times using various reagents. Journal of Thrombosis and Haemostasis. 12:1810-1815. 2014
- Role of phenotypic and genetic testing in managing clopidogrel therapy. Blood. 124:689-699. 2014
- Betrixaban (PRT054021): pharmacology, Dose Selection and Clinical Studies. Future Cardiology. 10:43-52. 2014
- Mandatory contrast-enhanced venography to detect deep-vein thrombosis (DVT) in studies of DVT prophylaxis: upsides and downsides. Thrombosis and Haemostasis. 111:10-13. 2014
- New oral anticoagulants for stroke prevention in atrial fibrillation: impact of study design, double counting and unexpected findings on interpretation of study results and conclusions. Thrombosis and Haemostasis. 112:798-807. 2014
- Organ-specific bleeding patterns of anticoagulant therapy: lessons from clinical trials. Thrombosis and Haemostasis. 112:918-923. 2014
- Solving the mystery of excessive warfarin-induced bleeding: A personal historical perspective. Thrombosis and Haemostasis. 112:853-856. 2014
- Left Atrial Appendage Occlusion Study II (LAAOS II). Canadian Journal of Cardiology. 29:1443-1447. 2013
- Venous thromboembolism prophylaxis: do trial results enable clinicians and patients to evaluate whether the benefits justify the risk? Proceedings of an Ad Hoc Working Group Meeting. Journal of Thrombosis and Haemostasis. 11:778-782. 2013
- Dabigatran attenuates thrombin generation to a lesser extent than warfarin: could this explain their differential effects on intracranial hemorrhage and myocardial infarction?. Journal of Thrombosis and Thrombolysis. 35:295-301. 2013
- A guide to GRADE guidelines for the readers of JTH. Journal of Thrombosis and Haemostasis. 11:1603-1608. 2013
- A response to–There’s madness in their methods. Journal of Thrombosis and Haemostasis. 11:785-786. 2013
- Erratum to: Relation between clopidogrel active metabolite levels and different platelet aggregation methods in patients receiving clopidogrel and aspirin. Journal of Thrombosis and Thrombolysis. 35:130-130. 2013
- Relation between clopidogrel active metabolite levels and different platelet aggregation methods in patients receiving clopidogrel and aspirin. Journal of Thrombosis and Thrombolysis. 34:429-436. 2012
- Subtle differences in commercial heparins can have serious consequences for cardiopulmonary bypass patients: A randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery. 144:944-950.e3. 2012
- Translational Success Stories. Circulation Research. 111:920-929. 2012
- Aspirin response variability after major orthopedic surgery. Thrombosis Research. 130:216-220. 2012
- Direct thrombin inhibitors in cardiovascular disease. Nature Reviews Cardiology. 9:402-414. 2012
- The effect of blood storage duration on in‐hospital mortality: a randomized controlled pilot feasibility trial. Transfusion. 52:1203-1212. 2012
- Reversal of the anti‐platelet effects of aspirin and clopidogrel. Journal of Thrombosis and Haemostasis. 10:521-528. 2012
- Antiplatelet Drugs. Chest. 141:e89S-e119S. 2012
- Randomized controlled trial of a new portable calf compression device (Venowave) for prevention of venous thrombosis in high‐risk neurosurgical patients. Journal of Thrombosis and Haemostasis. 10:229-235. 2012
- Approach to outcome measurement in the prevention of thrombosis in surgical and medical patients: Antithrombotic Therapy and Prevention of Thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 141:e185S-e194S. 2012
- Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 141:53S-70S. 2012
- Net Clinical Benefit of Adding Clopidogrel to Aspirin Therapy in Patients With Atrial Fibrillation for Whom Vitamin K Antagonists Are Unsuitable. ACP journal club. 155:579-579. 2011
- Effect of Aspirin on Mortality in the Primary Prevention of Cardiovascular Disease. American Journal of Medicine. 124:621-629. 2011
- Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials. The BMJ. 342:d3036-d3036. 2011
- Antithrombin-heparin covalent complex reduces microemboli during cardiopulmonary bypass in a pig model. Blood. 116:5716-5723. 2010
- Effects ofCYP2C19Genotype on Outcomes of Clopidogrel Treatment. New England Journal of Medicine. 363:1704-1714. 2010
- New antithrombotic agents—insights from clinical trials. Nature Reviews Cardiology. 7:498-509. 2010
- Dabigatran: ready for prime time?. Polskie Archiwum Medycyny Wewnetrznej. 120:137-142. 2010
- Erratum. Vascular. 18:121-121. 2010
- How can we reduce disagreement among guidelines for venous thromboembolism prevention?. Journal of Thrombosis and Haemostasis. 8:675-677. 2010
- Comparison of the anticoagulant intensities of fondaparinux and enoxaparin in the organization to assess strategies in acute ischemic syndromes (OASIS)‐5 trial. Journal of Thrombosis and Haemostasis. 8:243-249. 2010
- Electrical Foot Stimulation: A Potential New Method of Deep Venous Thrombosis Prophylaxis. Vascular. 18:20-27. 2010
- The vexing problem of guidelines and conflict of interest: a potential solution. ACP journal club. 152:738-741. 2010
- Deep Vein Thrombosis Prophylaxis: Response. Chest. 136:1700-1701. 2009
- Accelerated Infusion of Streptokinase for the Treatment of Left-Sided Prosthetic Valve Thrombosis. Circulation. 120:1108-1114. 2009
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation. New England Journal of Medicine. 361:1139-1151. 2009
- Clinical experts or methodologists to write clinical guidelines?. The Lancet. 374:273-275. 2009
- Does acetyl salicylic acid (ASA) have a role in the prevention of venous thromboembolism?. British Journal of Haematology. 146:142-149. 2009
- Duration of anticoagulant therapy for venous thromboembolism. Medical Journal of Australia. 190:659-660. 2009
- Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation. New England Journal of Medicine. 360:2066-2078. 2009
- American Association of Orthopedic Surgeons and American College of Chest Physicians Guidelines for Venous Thromboembolism Prevention in Hip and Knee Arthroplasty Differ. Chest. 135:513-520. 2009
- New oral anticoagulants: not quite there yet. Polskie Archiwum Medycyny Wewnetrznej. 119:53-59. 2009
- Platelet ADP-receptor antagonists for cardiovascular disease: past, present and future. Nature Reviews Cardiology. 5:766-780. 2008
- Guidelines for anticoagulant use in acute coronary syndromes – Authors' reply. The Lancet. 372:533-534. 2008
- Parenteral anticoagulants: American college of chest physicians evidence-based clinical practice guidelines (8th edition) (vol 133, pg 141S, 2008). Chest. 134:474-474. 2008
- Antiplatelet Drugs. Chest. 133:199S-233S. 2008
- Antithrombotic and Thrombolytic Therapy. Chest. 133:110S-112S. 2008
- Executive Summary. Chest. 133:71S-109S. 2008
- New Antithrombotic Drugs. Chest. 133:234S-256S. 2008
- Parenteral Anticoagulants. Chest. 133:141S-159S. 2008
- Pharmacology and Management of the Vitamin K Antagonists. Chest. 133:160S-198S. 2008
- Reflecting on Eight Editions of the American College of Chest Physicians Antithrombotic Guidelines. Chest. 133:1293-1295. 2008
- Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy. Chest. 133:844S-886S. 2008
- Guidelines for anticoagulant use in acute coronary syndromes. The Lancet. 371:1559-1561. 2008
- Evaluation of a venous-return assist device to treat severe post-thrombotic syndrome (VENOPTS). Thrombosis and Haemostasis. 99:623-629. 2008
- Monitoring the ACTIVE-W trial: Some issues in monitoring a noninferiority trial. American Heart Journal. 155:33-41. 2008
- Beyond Unfractionated Heparin and Warfarin. Circulation. 116:552-560. 2007
- Association between asymptomatic deep vein thrombosis detected by venography and symptomatic venous thromboembolism in patients undergoing elective hip or knee surgery. Journal of Thrombosis and Haemostasis. 5:1438-1443. 2007
- Anticoagulation for venous thromboembolism. The BMJ. 334:645-645. 2007
- Heparin resistance in acute coronary syndromes. Journal of Thrombosis and Thrombolysis. 23:93-100. 2007
- Risk of Thrombosis With Lenalidomide and Its Prevention With Aspirin. Chest. 131:275-277. 2007
- Bleeding and management of bleeding. European Heart Journal, Supplement. 8:G38-G45. 2006
- Comparison of Fixed-Dose Weight-Adjusted Unfractionated Heparin and Low-Molecular-Weight Heparin for Acute Treatment of Venous Thromboembolism. Journal of the American Medical Association (JAMA). 296:935-935. 2006
- Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes. New England Journal of Medicine. 354:1464-1476. 2006
- Monitoring unfractionated heparin with the aPTT: Time for a fresh look. Thrombosis and Haemostasis. 96:547-552. 2006
- Vena cava filters reduced long-term risk for pulmonary embolism in proximal deep venous thrombosis. ACP journal club. 144:18-18. 2006
- Prevention of venous thromboembolism after surgery: A review of enoxaparin. British Journal of Surgery. 79:495-498. 2005
- The (Variable) Definition of Benefit in the Case of Clopidogrel vs Aspirin—Reply. JAMA Internal Medicine. 165:1310-1310. 2005
- Heparin-Induced Skin Lesions and Other Unusual Sequelae of the Heparin-Induced Thrombocytopenia Syndrome. Chest. 127:1857-1861. 2005
- New anticoagulants. Blood. 105:453-463. 2005
- The multiple faces of the partial thromboplastin time APTT. Journal of Thrombosis and Haemostasis. 2:2250-2252. 2004
- The multiple faces of the partial thromboplastin time APTT. Journal of Thrombosis and Haemostasis. 2:2254-2256. 2004
- Comparative Benefits of Clopidogrel and Aspirin in High-Risk Patient Populations. JAMA Internal Medicine. 164:2106-2106. 2004
- Heparin and Low-Molecular-Weight Heparin. Chest. 126:188S-203S. 2004
- New Anticoagulant Drugs. Chest. 126:265S-286S. 2004
- Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects. Chest. 126:234S-264S. 2004
- The Pharmacology and Management of the Vitamin K Antagonists. Chest. 126:204S-233S. 2004
- The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 126:172S-173S. 2004
- Use of Antithrombotic Agents During Pregnancy. Chest. 126:627S-644S. 2004
- Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery?. Journal of Thoracic and Cardiovascular Surgery. 128:211-219. 2004
- Laboratory monitoring of low‐molecular‐weight heparin therapy. Journal of Thrombosis and Haemostasis. 2:1003-1003. 2004
- Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor. Journal of Thrombosis and Haemostasis. 2:743-749. 2004
- Suboptimal Monitoring and Dosing of Unfractionated Heparin. ACP journal club. 140:582-582. 2004
- Establishing an Optimal Therapeutic Range for Coumarins. JAMA Internal Medicine. 164:588-588. 2004
- Randomized Trial of Warfarin Nomograms. ACP journal club. 140:488-488. 2004
- Randomized Trial of Warfarin Nomograms. Annals of Internal Medicine. 140:490-490. 2004
- Treatment of Heparin-Induced Thrombocytopenia. JAMA Internal Medicine. 164:361-361. 2004
- Expert Consensus Document on the Use of Antiplatelet Agents The Task Force on the Use of Antiplatelet Agents in Patients with Atherosclerotic Cardiovascular Disease of the European Society of Cardiology. European Heart Journal. 25:166-181. 2004
- Advances and Contemporary Issues in Prophylaxis for Deep Vein Thrombosis. Chest. 124:347S-348S. 2003
- Advances and contemporary issues in prophylaxis for deep vein thrombosis.. Chest. 124:347S-348S. 2003
- Controversies in Timing of the First Dose of Anticoagulant Prophylaxis Against Venous Thromboembolism After Major Orthopedic Surgery. Chest. 124:379S-385S. 2003
- Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery.. Chest. 124:379S-385S. 2003
- Temporal Trends in Prevention of Venous Thromboembolism Following Primary Total Hip or Knee Arthroplasty 1996–2001. Chest. 124:349S-356S. 2003
- Temporal trends in prevention of venous thromboembolism following primary total hip or knee arthroplasty 1996-2001: findings from the Hip and Knee Registry.. Chest. 124:349S-356S. 2003
- An Improved Definition of Immune Heparin-Induced Thrombocytopenia in Postoperative Orthopedic Patients. JAMA Internal Medicine. 163:2518-2518. 2003
- Perioperative Management of Patients Receiving Oral Anticoagulants. JAMA Internal Medicine. 163:2532-2532. 2003
- A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome. New England Journal of Medicine. 349:1133-1138. 2003
- Relationship of Activated Partial Thromboplastin Time to Coronary Events and Bleeding in Patients With Acute Coronary Syndromes Who Receive Heparin. Circulation. 107:2884-2888. 2003
- Reduction of Out-of-Hospital Symptomatic Venous Thromboembolism by Extended Thromboprophylaxis With Low-Molecular-Weight Heparin Following Elective Hip Arthroplasty. JAMA Internal Medicine. 163:1362-1362. 2003
- Suboptimal Monitoring and Dosing of Unfractionated Heparin in Comparative Studies with Low-Molecular-Weight Heparin. ACP journal club. 138:720-720. 2003
- American Heart Association/American College of Cardiology Foundation guide to warfarin therapy11The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.This statement has been co-published in the April 1, 2003, issue of Circulation.This statement was approved by the American Heart Association Science Advisory and Coordinating Committee in October 2002 and by the American College of Cardiology Board of Trustees in February 2003. A single reprint is available by calling 800-242-8721 (US only) or writing the American Heart Association, Public Information, 7272 Greenville Ave, Dallas, TX 75231-4596. Ask for reprint No. 71-0254. To purchase additional reprints: up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 410-528-4426, fax 410-528-4264, or e-mail klbradle@lww.com. To make photocopies for personal or educational use, call the Copyright Clearance Center, 978-750-8400.. Journal of the American College of Cardiology. 41:1633-1652. 2003
- Low-molecular-weight heparin for anticougulation during continuous venovenous hemofiltration - Reply. JAMA Internal Medicine. 163:981-981. 2003
- American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy. Circulation. 107:1692-1711. 2003
- Choice of low molecular weight heparins. Journal of Thrombosis and Haemostasis. 1:598-599. 2003
- Choice of low molecular weight heparins.. Journal of Thrombosis and Haemostasis. 1:598. 2003
- Untitled - Response. Circulation. 106:E200-E201. 2002
- Is Impaired Renal Function a Contraindication to the Use of Low-Molecular-Weight Heparin?. JAMA Internal Medicine. 162:2605-2605. 2002
- Reasons for Resistance to Aspirin in Cardiovascular Disease. Circulation. 106:1-2. 2002
- Reasons for resistance to aspirin in cardiovascular disease.. Circulation. 106:e181-e182. 2002
- In vitro comparison of the effect of heparin, enoxaparin and fondaparinux on tests of coagulation. Thrombosis Research. 107:241-244. 2002
- Questioning the Treatment of Venous Thromboembolism. ACP journal club. 137:144-144. 2002
- Questioning the Treatment of Venous Thromboembolism. ACP journal club. 137:145-145. 2002
- Review: Extended out-of-hospital prophylaxis with heparin prevents deep venous thrombosis in elective hip arthroplasty. ACP journal club. 137:11-11. 2002
- How we diagnose and treat deep vein thrombosis. Blood. 99:3102-3110. 2002
- Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular Events. Circulation. 105:1650-1655. 2002
- Diagnosis and Treatment of Venous Thromboembolism. Annual Review of Medicine. 53:15-33. 2002
- Electrical Foot Stimulation and Implications for the Prevention of Venous Thromboembolic Disease. Thrombosis and Haemostasis. 88:200-204. 2002
- Prevention and Treatment of Postphlebitic Syndrome. JAMA Internal Medicine. 161:2105-2105. 2001
- Utility of ultrasound imaging of the lower extremities in the diagnostic approach in patients with suspected pulmonary embolism. Journal of Internal Medicine. 250:262-264. 2001
- Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation. New England Journal of Medicine. 345:494-502. 2001
- Conclusion. American Heart Journal. 142:S30-S30. 2001
- Introduction. American Heart Journal. 142:S1-S2. 2001
- New anticoagulants.. American Heart Journal. 142:S3-S8. 2001
- Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: Results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis). American Heart Journal. 142:237-243. 2001
- Management of Suspected Deep Venous Thrombosis in Outpatients by Using Clinical Assessment and d-dimer Testing. ACP journal club. 135:108-108. 2001
- Guide to Anticoagulant Therapy: Heparin. Arteriosclerosis, Thrombosis and Vascular Biology. 21:E9-E9. 2001
- Mechanism of Action and Pharmacology of Unfractionated Heparin. Arteriosclerosis, Thrombosis and Vascular Biology. 21:1094-1096. 2001
- Guide to Anticoagulant Therapy: Heparin. Circulation. 103:2994-3018. 2001
- Venous thromboembolism after long flights: are airlines to blame?. The Lancet. 357:1461-1462. 2001
- Developing a novel antithrombotic in the academic environment. Seminars in Hematology. 38:4-11. 2001
- Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. Gobal Use of Strategies To Open occluded arteries in acute coronary syndromes.. Journal of the American College of Cardiology. 37:1001-1007. 2001
- Clinical Trials That Have Influenced the Treatment of Venous Thromboembolism: A Historical Perspective. ACP journal club. 134:409-409. 2001
- Hypersulfated Low Molecular Weight Heparin with Reduced Affinity for Antithrombin Acts as an Anticoagulant by Inhibiting Intrinsic Tenase and Prothrombinase. Journal of Biological Chemistry. 276:9755-9761. 2001
- Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. Journal of the American College of Cardiology. 37:1001-1007. 2001
- Use of a Fixed Activated Partial Thromboplastin Time Ratio to Establish a Therapeutic Range for Unfractionated Heparin. JAMA Internal Medicine. 161:385-385. 2001
- Effects of long-term, moderate-intensity oral anticoagulation in addition to aspirin in unstable angina. Journal of the American College of Cardiology. 37:475-484. 2001
- Vitamin K in anticoagulation therapy. The Lancet. 357:637-637. 2001
- Fibrinolytic Variables in Patients with Recurrent Venous Thrombosis: a Prospective Cohort Study. Thrombosis and Haemostasis. 85:390-394. 2001
- Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety. Chest. 119:64S-94S. 2001
- Managing Oral Anticoagulant Therapy. Chest. 119:22S-38S. 2001
- Managing oral anticoagulant therapy.. Chest. 119:22S-38S. 2001
- New Anticoagulant Drugs. Chest. 119:95S-107S. 2001
- New anticoagulant drugs. Chest. 119:95S-107S. 2001
- Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range. Chest. 119:8S-21S. 2001
- Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range.. Chest. 119:8S-21S. 2001
- Platelet-Active Drugs. Chest. 119:39S-63S. 2001
- Platelet-active drugs : the relationships among dose, effectiveness, and side effects.. Chest. 119:39S-63S. 2001
- The Sixth (2000) ACCP Guidelines for Antithrombotic Therapy for Prevention and Treatment of Thrombosis. Chest. 119:1S-2S. 2001
- The sixth (2000) ACCP guidelines for antithrombotic therapy for prevention and treatment of thrombosis. American College of Chest Physicians.. Chest. 119:1S-2S. 2001
- Use of Antithrombotic Agents During Pregnancy. Chest. 119:122S-131S. 2001
- Use of antithrombotic agents during pregnancy.. Chest. 119:122S-131S. 2001
- The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme. Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. European Heart Journal. 21:2033-2041. 2000
- Treatment of Proximal Deep Vein Thrombosis With a Novel Synthetic Compound (SR90107A/ORG31540) With Pure Anti–Factor Xa Activity. Circulation. 102:2726-2731. 2000
- Safety of Withholding Heparin in Pregnant Women with a History of Venous Thromboembolism. New England Journal of Medicine. 343:1439-1444. 2000
- Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial. The Lancet. 356:1551-1553. 2000
- Effect of a Preoperative Intervention on Preoperative and Postoperative Outcomes in Low-Risk Patients Awaiting Elective Coronary Artery Bypass Graft Surgery. ACP journal club. 133:253-253. 2000
- Ardeparin Sodium for Extended Out-of-Hospital Prophylaxis against Venous Thromboembolism after Total Hip or Knee Replacement. ACP journal club. 132:853-853. 2000
- Postthrombotic Syndrome After Hip or Knee Arthroplasty. JAMA Internal Medicine. 160:669-672. 2000
- Oral Anticoagulation Treatment in the Elderly. JAMA Internal Medicine. 160:470-470. 2000
- Management of Patients with Hereditary Hypercoagulable Disorders. Annual Review of Medicine. 51:169-185. 2000
- The emerging role of low-molecular-weight heparin in cardiovascular medicine. Progress in Cardiovascular Diseases. 42:235-246. 2000
- A Comparison of the Safety and Efficacy of Oral Antiocoagulation for the Treatment of Venous Thromboembolic Disease in Patients with or without Malignancy. Thrombosis and Haemostasis. 84:805-810. 2000
- Derivation of a Simple Clinical Model to Categorize Patients Probability of Pulmonary Embolism: Increasing the Models Utility with the SimpliRED D-dimer. Thrombosis and Haemostasis. 83:416-420. 2000
- The Binding of Unfractionated Heparin and Low Molecular Weight Heparin to Thrombin-Activated Human Endothelial Cells. Thrombosis Research. 96:373-381. 1999
- Anticoagulation of the Elderly Patient.. American Journal of Geriatric Cardiology. 8:289-299. 1999
- Thrombosis and anticoagulation. Seminars in Hematology. 36:118-132. 1999
- Thrombosis and anticoagulation.. Seminars in Hematology. 36:118-132. 1999
- Recurrent Venous Thrombosis and Heparin Therapy. JAMA Internal Medicine. 159:2029-2029. 1999
- Extended anticoagulation prevented recurrence after a first episode of idiopathic venous thromboembolism. Evidence-Based Medicine. 4:109. 1999
- Heparin and low-molecular-weight heparin: Mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety (vol 114, pg 495S, 1998). Chest. 115:1760-1760. 1999
- Erratum: New antithrombotic agents (The Lancet (1999) April 24 (1431)). The Lancet. 353:1804. 1999
- Intermittent compression units for severe post-phlebitic syndrome: a randomized crossover study.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 160:1303-1306. 1999
- New antithrombotic agents. The Lancet. 353:1431-1436. 1999
- Prognosis in acute pulmonary embolism. The Lancet. 353:1375-1376. 1999
- A Comparison of Three Months of Anticoagulation with Extended Anticoagulation for a First Episode of Idiopathic Venous Thromboembolism. New England Journal of Medicine. 340:901-907. 1999
- A Histomorphometric Evaluation of Heparin-Induced Bone Loss After Discontinuation of Heparin Treatment in Rats. Blood. 93:1231-1236. 1999
- Vasoflux, a New Anticoagulant With a Novel Mechanism of Action. Circulation. 99:682-689. 1999
- A Randomized Trial Comparing 5-mg and 10-mg Warfarin Loading Doses. JAMA Internal Medicine. 159:46-46. 1999
- Treatment of Venous Thromboembolism. Thrombosis and Haemostasis. 82:870-877. 1999
- Sensitivity and Specificity of a Rapid Whole-Blood Assay for D-Dimer in the Diagnosis of Pulmonary Embolism. ACP journal club. 129:1006-1006. 1998
- The Role of Venous Ultrasonography in the Diagnosis of Suspected Deep Venous Thrombosis and Pulmonary Embolism. ACP journal club. 129:1044-1044. 1998
- Use of a Clinical Model for Safe Management of Patients with Suspected Pulmonary Embolism. ACP journal club. 129:997-997. 1998
- Reversal of the Anticoagulant Effects of Warfarin by Vitamin K1. Chest. 114:1505-1508. 1998
- Heparin and Low-Molecular-Weight Heparin. Chest. 114:489S-510S. 1998
- Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.. Chest. 114:489S-510S. 1998
- New Antithrombotic Agents. Chest. 114:715S-727S. 1998
- Oral Anticoagulants. Chest. 114:445S-469S. 1998
- Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range.. Chest. 114:445S-469S. 1998
- Platelet-active drugs: the relationships among dose, effectiveness, and side effects.. Chest. 114:470S-488S. 1998
- Use of Antithrombotic Agents During Pregnancy. Chest. 114:524S-530S. 1998
- Use of antithrombotic agents during pregnancy.. Chest. 114:524S-530S. 1998
- Use of bedside activated partial thromboplastin time monitor to adjust heparin dosing after thrombolysis for acute myocardial infarction: Results of GUSTO-I. American Heart Journal. 136:868-876. 1998
- Use of bedside activated partial thromboplastin time monitor to adjust heparin dosing after thrombolysis for acute myocardial infarction: results of GUSTO-I. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.. American Heart Journal. 136:868-876. 1998
- Low-Molecular-Weight Heparin. Circulation. 98:1575-1582. 1998
- Assessment of Outpatient Treatment of Deep-Vein Thrombosis With Low-Molecular-Weight Heparin. JAMA Internal Medicine. 158:2001-2001. 1998
- A novel antithrombin-heparin covalent complex. Blood Coagulation and Fibrinolysis. 9:587-596. 1998
- Hirudin causes more bleeding than heparin in a rabbit ear bleeding model. Translational Research. 132:181-185. 1998
- Recent clinical trials in the treatment of venous thromboembolism and unstable angina with low molecular weight heparins. Current Opinion in Hematology. 5:B159-B159. 1998
- Evidence for the Needs of Out-of-Hospital Thrombosis Prophylaxis. Chest. 114:113S-114S. 1998
- The Incidence of Symptomatic Venous Thromboembolism After Enoxaparin Prophylaxis in Lower Extremity Arthroplasty. Chest. 114:115S-118S. 1998
- Low-molecular-weight heparin for the treatment of venous thromboembolism.. American Heart Journal. 135:S336-S342. 1998
- Randomized Comparison of Direct Thrombin Inhibition Versus Heparin in Conjunction With Fibrinolytic Therapy for Acute Myocardial Infarction: Results From the GUSTO-IIb Trial. Journal of the American College of Cardiology. 31:1493-1498. 1998
- Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-IIb) Investigators.. Journal of the American College of Cardiology. 31:1493-1498. 1998
- Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial Infarction. New England Journal of Medicine. 338:1488-1497. 1998
- Characterization of the stress-inducing effects of homocysteine. Biochemical Journal. 332:213-221. 1998
- A simple clinical model for the diagnosis of deep‐vein thrombosis combined with impedance plethysmography: potential for an improvement in the diagnostic process. Journal of Internal Medicine. 243:15-23. 1998
- The Effects of Standard and Low Molecular Weight Heparin on Bone Nodule Formation In Vitro. Thrombosis and Haemostasis. 80:413-417. 1998
- The Occurrence of Subsequent Malignancy in Patients Presenting with Deep Vein Thrombosis: Results from a Historical Cohort Study. Thrombosis and Haemostasis. 79:19-22. 1998
- Thrombolytic therapy for pulmonary embolism: is it effective? Is it safe? When is it indicated?. JAMA Internal Medicine. 157:2550-2556. 1997
- The variable anticoagulant response to unfractionated heparin in vivo reflects binding to plasma proteins rather than clearance. Translational Research. 130:649-655. 1997
- Duration of anticoagulant therapy after first episode of venous thrombosis in patients with inherited thrombophilia. JAMA Internal Medicine. 157:2174-2177. 1997
- Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis.. Seminars in Hematology. 34:20-25. 1997
- Is There a Relationship Between the Intensity of Heparin Treatment and Recurrent Thomboembolism?. Clinical and Applied Thrombosis/Hemostasis. 3:S64-S67. 1997
- Guidelines for use of anticoagulants - Response. Circulation. 96:2099-2099. 1997
- Low-Molecular-Weight Heparin in the Treatment of Patients with Venous Thromboembolism. New England Journal of Medicine. 337:657-662. 1997
- Antithrombotic drugs for thromboembolic disorders: A lesson in evidence-based medicine. American Journal of Health-System Pharmacy. 54:1992-1994. 1997
- Reply: Warfarin: Less May Be Better. ACP journal club. 127:333-333. 1997
- Comparison of the Effects of Two Doses of Recombinant Hirudin Compared With Heparin in Patients With Acute Myocardial Ischemia Without ST Elevation. Circulation. 96:769-777. 1997
- Induction of the Acute-Phase Reaction Increases Heparin-Binding Proteins in Plasma. Arteriosclerosis, Thrombosis and Vascular Biology. 17:1568-1574. 1997
- The use of D-dimer testing and impedance plethysmographic examination in patients with clinical indications of deep vein thrombosis. JAMA Internal Medicine. 157:1077-1081. 1997
- Management of Anticoagulation before and after Elective Surgery. New England Journal of Medicine. 336:1506-1511. 1997
- A Histomorphometric Comparison of the Effects of Heparin and Low-Molecular-Weight Heparin on Cancellous Bone in Rats. Blood. 89:3236-3242. 1997
- A comparison of compression ultrasound with color Doppler ultrasound for the diagnosis of symptomless postoperative deep vein thrombosis. JAMA Internal Medicine. 157:765-768. 1997
- Low-Molecular-Weight Heparin for the Out-of-Hospital Treatment of Venous Thrombosis: Rationale and Clinical Results. Seminars in Vascular Medicine. 23:77-81. 1997
- Comparison of 5-mg and 10-mg Loading Doses in Initiation of Warfarin Therapy. ACP journal club. 126:133-133. 1997
- Effect of Nonspecific Binding to Plasma Proteins on the Antithrombin Activities of Unfractionated Heparin, Low-Molecular-Weight Heparin, and Dermatan Sulfate. Circulation. 95:118-124. 1997
- Low Molecular Weight Heparin for the Out-of-Hospital Treatment of Venous Thrombosis: Rationale and Clinical Results. Thrombosis and Haemostasis. 78:689-692. 1997
- Low-Molecular-Weight Heparin Should Replace Unfractionated Heparin for Treatment of Venous Thrombosis and Unstable Angina.. Journal of Thrombosis and Thrombolysis. 4:349-351. 1997
- Newly Diagnosed Malignancy in Patients with VenousThromboembolism. Search or Wait and See?. Thrombosis and Haemostasis. 78:121-125. 1997
- Ardeparin plus graduated compression stockings prevented DVT after knee surgery. Evidence-Based Medicine. 1:213. 1996
- Familial Thrombophilia: A Review Analysis. Clinical and Applied Thrombosis/Hemostasis. 2:227-236. 1996
- Fish Oils and Low-Molecular-Weight Heparin for the Reduction of Restenosis After Percutaneous Transluminal Coronary Angioplasty. Circulation. 94:1553-1560. 1996
- Unfractionated versus Low-Molecular-Weight Heparin for Deep Venous Thrombosis. New England Journal of Medicine. 335:670-672. 1996
- Unfractionated versus low-molecular-weight heparin for deep venous thrombosis - Reply. New England Journal of Medicine. 335:671-672. 1996
- Histomorphometric analysis of the effects of standard heparin on trabecular bone in vivo. Blood. 88:1314-1320. 1996
- The relation between the activated partial thromboplastin time response and recurrence in patients with venous thrombosis treated with continuous intravenous heparin. JAMA Internal Medicine. 156:1677-1681. 1996
- Reliability of the international normalized ratio for monitoring the induction phase of warfarin: Comparison with the prothrombin time ratio. Translational Research. 128:214-217. 1996
- Management of Deep Vein Thrombosis and Pulmonary Embolism. Circulation. 93:2212-2245. 1996
- Multicentric evaluation of heparinase on aPTT, thrombin clotting time and a new PT reagent based on recombinant human tissue factor. Blood Coagulation and Fibrinolysis. 7:453-458. 1996
- Ardeparin (low-molecular-weight heparin) vs graduated compression stockings for the prevention of venous thromboembolism. A randomized trial in patients undergoing knee surgery. JAMA Internal Medicine. 156:851-856. 1996
- A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein Thrombosis. New England Journal of Medicine. 334:677-681. 1996
- Activated Partial Thromboplastin Time and Outcome After Thrombolytic Therapy for Acute Myocardial Infarction. Circulation. 93:870-878. 1996
- Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: Results of a meta-analysis. American Journal of Medicine. 100:269-277. 1996
- Comparison of the relative efficacy and safety of low-molecular-weight heparin and unfractionated heparin for the treatment of venous thrombosis.. Seminars in Vascular Medicine. 22 Suppl 2:7-12. 1996
- Low-Molecular-Weight Heparinoid Orgaran Is More Effective Than Aspirin in the Prevention of Venous Thromboembolism After Surgery for Hip Fracture. Circulation. 93:80-84. 1996
- Antiphospholipid antibodies and venous thromboembolism. Blood. 86:3685-3691. 1995
- Prolonged Antithrombin Activity of Low-Molecular-Weight Heparins. Circulation. 92:2819-2824. 1995
- DURATION OF ANTICOAGULANT-THERAPY FOR VENOUS THROMBOSIS - REPLY. New England Journal of Medicine. 333:1289-1289. 1995
- Duration of Anticoagulant Therapy for Venous Thrombosis. New England Journal of Medicine. 333:1288-1289. 1995
- Heparin-Induced Thrombocytopenia. New England Journal of Medicine. 333:1006-1007. 1995
- Aspirin and other platelet-active drugs. The relationship among dose, effectiveness, and side effects.. Chest. 108:247S-257S. 1995
- Hemorrhagic Complications of Anticoagulant Treatment. Chest. 108:276S-290S. 1995
- Hemorrhagic complications of anticoagulant treatment.. Chest. 108:276S-290S. 1995
- Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism.. Chest. 108:291S-301S. 1995
- Heparin: Mechanism of Action, Pharmacokinetics, Dosing Considerations, Monitoring, Efficacy, and Safety. Chest. 108:258S-275S. 1995
- Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.. Chest. 108:258S-275S. 1995
- New Antithrombotics. Chest. 108:471S-485S. 1995
- Oral Anticoagulants. Chest. 108:231S-246S. 1995
- Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range.. Chest. 108:231S-246S. 1995
- The effects of low molecular weight and standard heparin on calcium loss from fetal rat calvaria. Blood. 86:1368-1373. 1995
- Advances in antithrombotic drug therapy for coronary artery disease. European Heart Journal. 16:10-21. 1995
- New Anticoagulants Hirudin and Hirulog in the Treatment of Acute Coronary Syndromes. Cardiology in Review. 3:196-204. 1995
- The Optimal Duration of Anticoagulant Therapy for Venous Thrombosis. New England Journal of Medicine. 332:1710-1712. 1995
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin. New England Journal of Medicine. 332:1330-1336. 1995
- Accuracy of clinical assessment of deep-vein thrombosis. The Lancet. 345:1326-1330. 1995
- A Novel and Rapid Whole-Blood Assay for D-Dimer in Patients With Clinically Suspected Deep Vein Thrombosis. Circulation. 91:2184-2187. 1995
- Impedance Plethysmography for Suspected Deep-Vein Thrombosis-Reply. JAMA Internal Medicine. 155:776-776. 1995
- Heparins. Fibrinolysis and Proteolysis. 9:66-68. 1995
- INR reporting in Canadian medical laboratories. American Journal of Hematology. 48:237-239. 1995
- INR reporting in Canadian medical laboratories. Thrombosis Interest Group of Canada.. American Journal of Hematology. 48:237-239. 1995
- Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis. JAMA Internal Medicine. 155:601-607. 1995
- Deep Vein Thrombosis: Recovery or Recurrence?. Hospital Practice. 30:71-79. 1995
- Maximizing the benefits of thrombolytic therapy for acute myocardial infarction.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 152:819-822. 1995
- A Comparison of Lyophilized Artificially Depleted Plasmas and Lyophilized Plasmas From Patients Receiving Warfarin in Correcting for Coagulometer Effects on International Normalized Ratios. American Journal of Clinical Pathology. 103:366-371. 1995
- CARDIOVASCULAR TECHNOLOGY SYMPOSIUM. Canadian Journal of Cardiology. 11:251-252. 1995
- The Value of Plasma Calibrants in Correcting Coagulometer Effects on International Normalized Ratios:An International Multicenter Study. American Journal of Clinical Pathology. 103:358-365. 1995
- Starting prophylaxis for venous thromboembolism postoperatively. JAMA Internal Medicine. 155:366-372. 1995
- Thrombosis.. American Journal of Cardiology. 75:3B-4B. 1995
- Anticoagulation/platelet inhibition for atrial fibrillation. Coronary Artery Disease. 6:129-136. 1995
- Optimal intensity and monitoring warfarin. American Journal of Cardiology. 75:39B-42B. 1995
- introduction: Thrombosis. American Journal of Cardiology. 75:3B-4B. 1995
- Accuracy of Ultrasound for the Diagnosis of Deep Venous Thrombosis in Asymptomatic Patients after Orthopedic Surgery. ACP journal club. 122:47-47. 1995
- Advances in Antithrombotic Therapy: Novel Agents. Thrombosis and Haemostasis. 74:565-571. 1995
- Comparison of the Accuracy of Impedance Plethysmography and Compression Ultrasonography in Outpatients with Clinically Suspected Deep Vein Thrombosis. Thrombosis and Haemostasis. 74:1423-1427. 1995
- Optimal Duration of Oral Anticoagulant Therapy: A Randomized Trial Comparing Four Weeks with Three Months of Warfarin in Patients with Proximal Deep Vein Thrombosis. Thrombosis and Haemostasis. 74:606-611. 1995
- The Diagnosis of Pulmonary Embolism. Pathophysiology of Haemostasis and Thrombosis: international journal on haemostasis and thrombosis research. 25:72-87. 1995
- Very low-dose warfarin prophylaxis to prevent thromboembolism in women with metastatic breast cancer receiving chemotherapy: an economic evaluation.. Journal of Clinical Oncology. 13:42-46. 1995
- [Canadian Consensus Conference on Coronary Thrombolysis--current aspects].. Canadian Journal of Cardiology. 11:581-586. 1995
- Interactions of Warfarin with Drugs and Food. ACP journal club. 121:676-676. 1994
- Use of Hirulog in the prevention of venous thrombosis after major hip or knee surgery.. Circulation. 90:2385-2389. 1994
- Diagnostic tests for deep vein thrombosis. Clinical usefulness depends on probability of disease. JAMA Internal Medicine. 154:1921-1928. 1994
- Reevaluation of the sensitivity of impedance plethysmography for the detection of proximal deep vein thrombosis. JAMA Internal Medicine. 154:1930-1933. 1994
- Low molecular weight heparins. Current Opinion in Cardiology. 9:612-618. 1994
- Idiopathic deep venous thrombosis. Is a search for malignant disease justified?. JAMA Internal Medicine. 154:1310-1312. 1994
- Canadian Consensus Conference on Coronary Thrombolysis--1994 update.. Canadian Journal of Cardiology. 10:517-521. 1994
- Oral Anticoagulants-To the Editor. Chest. 105:1903-1903. 1994
- Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer. The Lancet. 343:886-889. 1994
- Low-Molecular-Weight Heparin vs. Warfarin for Prophylaxis against Deep-Vein Thrombosis. New England Journal of Medicine. 330:862-863. 1994
- Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association.. Circulation. 89:1449-1468. 1994
- Guide to anticoagulant therapy. Part 2: Oral anticoagulants. American Heart Association.. Circulation. 89:1469-1480. 1994
- Low molecular weight heparin: a critical analysis of clinical trials.. Pharmacological Reviews. 46:89-109. 1994
- WARFARIN AND ASPIRIN AFTER HEART-VALVE REPLACEMENT - REPLY. New England Journal of Medicine. 330:508-509. 1994
- Warfarin and Aspirin after Heart-Valve Replacement. New England Journal of Medicine. 330:507-509. 1994
- The international normalized ratio. A guide to understanding and correcting its problems. JAMA Internal Medicine. 154:282-288. 1994
- MONITORING HEPARIN-THERAPY - RESPONSE. Annals of Internal Medicine. 120:170-170. 1994
- Monitoring Heparin Therapy. ACP journal club. 120:169-169. 1994
- A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin. JAMA Internal Medicine. 154:49-56. 1994
- Graduated compression stockings in the prevention of postoperative venous thromboembolism. A meta-analysis. JAMA Internal Medicine. 154:67-72. 1994
- Effects on Thrombin Generation of Single Injections of Hirulog™ in Patients with Calf Vein Thrombosis. Thrombosis and Haemostasis. 72:523-525. 1994
- Ex-Vivo and In-Vitro Evidence that Low Molecular Weight Heparins Exhibit Less Binding to Plasma Proteins than Unfractionated Heparin. Thrombosis and Haemostasis. 71:300-304. 1994
- Factors Influencing the Reported Sensitivity and Specificity of Impedance Plethysmography for Proximal Deep Vein Thrombosis. Thrombosis and Haemostasis. 72:652-658. 1994
- Low molecular weight heparin: laboratory properties and clinical evaluation. A review.. British Journal of Surgery. 9-22. 1994
- Multicentric Evaluation of a New PT Reagent Based on Recombinant Human Tissue Factor and Synthetic Phospholipids. Thrombosis and Haemostasis. 71:292-299. 1994
- Oral Anticoagulant Therapy Recommendations. Chest. 105:328-328. 1994
- Distribution of thrombosis in patients with symptomatic deep vein thrombosis. Implications for simplifying the diagnostic process with compression ultrasound. JAMA Internal Medicine. 153:2777-2780. 1993
- Efficacy and Cost of Low-Molecular-Weight Heparin Compared with Standard Heparin for the Prevention of Deep Vein Thrombosis after Total Hip Arthroplasty. ACP journal club. 119:1105-1105. 1993
- The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival after Acute Myocardial Infarction. New England Journal of Medicine. 329:1615-1622. 1993
- HEPARIN-BINDING PROTEINS - CONTRIBUTION TO HEPARIN REBOUND AFTER CARDIOPULMONARY BYPASS. Circulation. 88:420-425. 1993
- Heparin binding proteins. Contribution to heparin rebound after cardiopulmonary bypass.. Circulation. 88:II420-II425. 1993
- New anticoagulant strategies.. Translational Research. 122:364-373. 1993
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction. New England Journal of Medicine. 329:673-682. 1993
- A Comparison of Aspirin with Placebo in Patients Treated with Warfarin after Heart-Valve Replacement. New England Journal of Medicine. 329:524-529. 1993
- Impedance Plethysmography and DVT Diagnosis. ACP journal club. 119:246-246. 1993
- Establishing a Therapeutic Range for Heparin Therapy. ACP journal club. 119:104-104. 1993
- Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy. JAMA Internal Medicine. 153:1441-1447. 1993
- Use of Antithrombotic Agents During Pregnancy. Obstetrical and Gynecological Survey. 48:392-395. 1993
- The use of an indwelling Teflon catheter for subcutaneous heparin administration during pregnancy. A randomized crossover study. JAMA Internal Medicine. 153:841-844. 1993
- Alpha 2-antiplasmin supplementation inhibits tissue plasminogen activator-induced fibrinogenolysis and bleeding with little effect on thrombolysis.. Journal of Clinical Investigation. 91:1343-1350. 1993
- Optimal dose for starting and maintaining low-dose aspirin. JAMA Internal Medicine. 153:700-702. 1993
- 125I-fibrinogen leg scanning: reassessment of its role for the diagnosis of venous thrombosis in post-operative patients.. Thrombosis and Haemostasis. 69:2-7. 1993
- 125I-Fibrinogen Leg Scanning: Reassessment of Its Role for the Diagnosis of Venous Thrombosis in Post-Operative Patients. Thrombosis and Haemostasis. 69:002-007. 1993
- An Antithrombin III Assay Based on Factor Xa Inhibition Provides a More Reliable Test to Identify Congenital Antithrombin III Deficiency Than an Assay Based on Thrombin Inhibition. Thrombosis and Haemostasis. 69:231-235. 1993
- Comparison of the Non-Specific Binding of Unfractionated Heparin and Low Molecular Weight Heparin (Enoxaparin) to Plasma Proteins. Thrombosis and Haemostasis. 70:625-630. 1993
- Limitations of Impedance Plethysmography in the Diagnosis of Clinically Suspected Deep-Vein Thrombosis. ACP journal club. 118:25-25. 1993
- Low Molecular Weight Heparin. Thrombosis and Haemostasis. 70:204-207. 1993
- The Additive Effect of Low Molecular Weight Heparins on Thrombin Inhibition by Dermatan Sulfate. Thrombosis and Haemostasis. 70:443-447. 1993
- Type 1 plasminogen activator inhibitor is not an acute phase reactant in rats. Lack of IL-6- and hepatocyte-dependent synthesis.. Journal of Immunology. 150:225-235. 1993
- Use of warfarin (coumarin).. Heart disease and stroke : a journal for primary care physicians. 2:209-216. 1993
- Thrombosis in Antithrombin-III Deficiency. ACP journal club. 117:875-875. 1992
- Heparin and low-molecular weight heparins. Coronary Artery Disease. 3:990-1002. 1992
- Antithrombotic Agents in Coronary Artery Disease. Chest. 102:456S-481S. 1992
- Antithrombotic therapy. Introduction.. Chest. 102:303S-304S. 1992
- Aspirin and Other Platelet-Active Drugs. Chest. 102:327S-336S. 1992
- Aspirin and other platelet-active drugs. The relationship between dose, effectiveness, and side effects.. Chest. 102:327S-336S. 1992
- Evidence that postoperative fibrinolytic shutdown is mediated by plasma factors that stimulate endothelial cell type I plasminogen activator inhibitor biosynthesis. Blood. 80:1758-1764. 1992
- Hemorrhagic Complications of Anticoagulant Treatment. Chest. 102:352S-363S. 1992
- Hemorrhagic Complications of Thrombolytic Therapy in the Treatment of Myocardial Infarction and Venous Thromboembolism. Chest. 102:364S-373S. 1992
- Hemorrhagic complications of anticoagulant treatment.. Chest. 102:352S-363S. 1992
- Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism.. Chest. 102:364S-373S. 1992
- Heparin: Mechanism of Action, Pharmacokinetics, Dosing Considerations, Monitoring, Efficacy, and Safety. Chest. 102:337S-351S. 1992
- Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.. Chest. 102:337S-351S. 1992
- Oral Anticoagulants. Chest. 102:312S-326S. 1992
- Oral anticoagulant therapy. Urgent need for standardization.. Circulation. 86:1332-1335. 1992
- Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest. 102:312S-326. 1992
- Overview of low molecular weight heparins and heparinoids: basic and clinical aspects.. Internal Medicine Journal. 22:487-495. 1992
- Use of Antithrombotic Agents During Pregnancy. Chest. 102:385S-390S. 1992
- Use of antithrombotic agents during pregnancy.. Chest. 102:385S-390S. 1992
- Heparin enhances active site-dependent binding of tissue-type plasminogen activator to endothelial cells. Blood. 80:1486-1495. 1992
- A Low-Molecular-Weight Heparinoid Compared with Unfractionated Heparin in the Prevention of Deep Vein Thrombosis in Patients with Acute Ischemic Stroke. ACP journal club. 117:353-357. 1992
- Sustained antithrombotic activity of hirudin after its plasma clearance: comparison with heparin. Blood. 80:960-965. 1992
- Subcutaneous compared with intravenous heparin for deep vein thrombosis.. ACP journal club. 117:266. 1992
- Inadequate monitoring of warfarin dosage [letter] [see comments]. Blood. 80:562-563. 1992
- Inhibition of the amplification reactions of blood coagulation by site-specific inhibitors of α-thrombin. Biochemical Journal. 283:893-897. 1992
- Thrombosis in Antithrombin-III-deficient Persons. ACP journal club. 116:754-761. 1992
- Antithrombotic therapy in deep vein thrombosis and pulmonary embolism. American Heart Journal. 123:1115-1122. 1992
- Antithrombotic therapy in deep vein thrombosis and pulmonary embolism.. American Heart Journal. 123:1115-1122. 1992
- ORGARAN - EXTENDING THE FRONTIERS OF VENOUS THROMBOSIS PROPHYLAXIS - INTRODUCTION. Pathophysiology of Haemostasis and Thrombosis: international journal on haemostasis and thrombosis research. 22:57-57. 1992
- ORGARAN - EXTENDING THE FRONTIERS OF VENOUS THROMBOSIS PROPHYLAXIS - SUMMARY AND CONCLUSIONS. Pathophysiology of Haemostasis and Thrombosis: international journal on haemostasis and thrombosis research. 22:112-112. 1992
- Antithrombins: Their Potential as Antithrombotic Agents. Annual Review of Medicine. 43:9-16. 1992
- Substandard monitoring of warfarin in North America. Time for change. JAMA Internal Medicine. 152:257-258. 1992
- ORAL ANTICOAGULANT DRUGS - REPLY. New England Journal of Medicine. 326:68-69. 1992
- Antithrombins: Their Potential As Antithrombotic Agents. Annual Review of Medicine. 43:9-16. 1992
- Heparin Binding to Plasma Proteins, an Important Mechanism for Heparin Resistance. Thrombosis and Haemostasis. 67:639-643. 1992
- Low molecular weight heparin. Blood. 79:1-17. 1992
- The Effect of Thrombin Inhibitors on Tissue Plasminogen Activator Induced Thrombolysis in a Rat Model. Thrombosis and Haemostasis. 68:064-068. 1992
- Ventilation-Perfusion Lung Scanning and the Diagnosis of Pulmonary Embolism: Improvement of Observer Agreement by the Use of a Lung Segment Reference Chart. Thrombosis and Haemostasis. 68:245-249. 1992
- HEPARIN - REPLY. New England Journal of Medicine. 325:1585-1586. 1991
- Stroke Prevention in Nonvalvular Atrial Fibrillation. ACP journal club. 115:727-736. 1991
- Influence of low-intensity warfarin treatment on patients' perceptions of quality of life. JAMA Internal Medicine. 151:1921-1922. 1991
- A critical review of the evidence supporting a relationship between impaired fibrinolytic activity and venous thromboembolism. JAMA Internal Medicine. 151:1721-1731. 1991
- A critical review of the relationship between impaired fibrinolysis and myocardial infarction. American Heart Journal. 122:545-551. 1991
- LMW Heparin for Deep Vein Thrombosis. ACP journal club. 115:231-232. 1991
- LOW-MOLECULAR-WEIGHT HEPARIN FOR DEEP-VEIN THROMBOSIS. Annals of Internal Medicine. 115:232-232. 1991
- Principles and practice of coronary thrombolysis and conjunctive treatment. American Journal of Cardiology. 68:382-388. 1991
- Pulmonary Embolism in the Elderly. Cardiology Clinics. 9:457-474. 1991
- DRUG-THERAPY - ORAL ANTICOAGULANT DRUGS. New England Journal of Medicine. 324:1865-1875. 1991
- Oral Anticoagulant Drugs. New England Journal of Medicine. 324:1865-1875. 1991
- Heparin. New England Journal of Medicine. 324:1565-1574. 1991
- Prevention of Deep Vein Thrombosis after Elective Hip Surgery. ACP journal club. 114:545-551. 1991
- VENOUS THROMBOEMBOLISM IN SURGERY - A RISK TO BE PREVENTED. American Journal of Surgery. 161:505-505. 1991
- A standard heparin nomogram for the management of heparin therapy. JAMA Internal Medicine. 151:333-337. 1991
- Measurement of the Activated Partial Thromboplastin Time from a Capillary (fingerstick) Sample of Whole Blood: A New Method for Monitoring Heparin Therapy. American Journal of Clinical Pathology. 95:222-227. 1991
- Deep Vein Thrombosis: New Non-Invasive Diagnostic Tests. Thrombosis and Haemostasis. 66:133-137. 1991
- Heparin as an adjunctive treatment after thrombolytic therapy for acute myocardial infarction. American Journal of Cardiology. 67:3-11. 1991
- Reliability of Non-Invasive Tests for the Diagnosis of Venous Thrombosis. Thrombosis and Haemostasis. 65:221-222. 1991
- Standard and Low Molecular Weight Heparin Have no Effect on Tissue Plasminogen Activator Induced Plasma Clot Lysis or Fibrinogenolysis. Thrombosis and Haemostasis. 65:541-544. 1991
- The Relationship of Antiphospholipid Antibodies to Thromboembolic Disease in Systemic Lupus Erythematosus: A Cross-Sectional Study. Thrombosis and Haemostasis. 66:520-524. 1991
- A Randomized Trial of a Single Bolus Dosage Regimen of Recombinant Tissue Plasminogen Activator in Patients with Acute Pulmonary Embolism. Chest. 98:1473-1479. 1990
- Use of plasminogen activators in venous thrombosis. World Journal of Surgery. 14:688-693. 1990
- Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.. Journal of Clinical Investigation. 86:385-391. 1990
- 10 Anticoagulant therapy in venous thromboembolism. Best Practice and Research in Clinical Haematology. 3:685-692. 1990
- 4 Clinical potential of low molecular weight heparins. Best Practice and Research in Clinical Haematology. 3:545-554. 1990
- Risks to the Fetus of Anticoagulant Therapy during Pregnancy. Obstetrical and Gynecological Survey. 45:371-371. 1990
- Heparin for 5 Days as Compared with 10 Days in the Initial Treatment of Proximal Venous Thrombosis. New England Journal of Medicine. 322:1260-1264. 1990
- A NEW SHORT INFUSION DOSAGE REGIMEN OF RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR IN PATIENTS WITH VENOUS THROMBOEMBOLIC DISEASE. Chest. 97:S168-S171. 1990
- A New Short Infusion Dosage Regimen of Recombinant Tissue Plasminogen Activator in Patients with Venous Thromboembolic Disease. Chest. 97:168S-171S. 1990
- The diagnosis and treatment of thrombosis in the cancer patient.. Seminars in Oncology. 17:160-171. 1990
- Tissue Plasminogen Activator (rt-PA) vs Heparin in Deep Vein Thrombosis. Chest. 97:172S-175S. 1990
- Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis. Results of a randomized trial.. Chest. 97:172S-175S. 1990
- Relationship between vessel wall 13-HODE synthesis and vessel wall thrombogenecity following injury: Influence of salicylate and dipyridamole treatment. Thrombosis Research. 57:383-392. 1990
- A Comparison of General Anesthesia and Regional Anesthesia as a Risk Factor for Deep Vein Thrombosis Following Hip Surgery: A Critical Review. Thrombosis and Haemostasis. 64:497-500. 1990
- Contribution of Red Blood Cells to the Saturable Mechanism of Heparin Clearance. Thrombosis and Haemostasis. 64:559-563. 1990
- From unfractionated heparins to low molecular weight heparins.. British Journal of Surgery. 556:42-50. 1990
- Heparin Effect on Bone Density. Thrombosis and Haemostasis. 64:286-289. 1990
- Neutralization of Enoxaparine-lnduced Bleeding by Protamine Sulfate. Thrombosis and Haemostasis. 63:271-274. 1990
- VENOUS THROMBOEMBOLISM MANAGING THE RISK - PROCEEDINGS OF A SYMPOSIUM HELD IN BERLIN OCTOBER 6TH-7TH 1989 - SUMMARY. Acta Chirurgica Scandinavica. 121-121. 1990
- Detection of previous proximal venous thrombosis with Doppler ultrasonography and photoplethysmography. JAMA Internal Medicine. 149:2255-2257. 1989
- Heparin therapy during pregnancy. Risks to the fetus and mother. JAMA Internal Medicine. 149:2233-2236. 1989
- Congenital antithrombin III deficiency. American Journal of Medicine. 87:S34-S38. 1989
- Intermittent compression units for the postphlebitic syndrome. A pilot study. JAMA Internal Medicine. 149:1651-1652. 1989
- Effects of Dermatan Sulfate and Heparin on Inhibition of Thrombus Growth in Vivo. Annals of the New York Academy of Sciences. 556:304-312. 1989
- Heparin Therapy in Venous Thromboembolism. Annals of the New York Academy of Sciences. 556:378-385. 1989
- Preface. Annals of the New York Academy of Sciences. 556:xi-xi. 1989
- A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip. JAMA Internal Medicine. 149:771-774. 1989
- Prevention of deep vein thrombosis in potential neurosurgical patients. A randomized trial comparing graduated compression stockings alone or graduated compression stockings plus intermittent pneumatic compression with control. JAMA Internal Medicine. 149:679-681. 1989
- Comparison of High-Dose with Low-Dose Subcutaneous Heparin to Prevent Left Ventricular Mural Thrombosis in Patients with Acute Transmural Anterior Myocardial Infarction. New England Journal of Medicine. 320:352-357. 1989
- ASPIRIN AND OTHER PLATELET ACTIVE-DRUGS - RELATIONSHIP AMONG DOSE, EFFECTIVENESS, AND SIDE-EFFECTS. Chest. 95:S12-S18. 1989
- Anticoagulants During Pregnancy. Annual Review of Medicine. 40:79-86. 1989
- Antithrombotic Agents in Coronary Artery Disease. Chest. 95:52S-72S. 1989
- Antithrombotic and bleeding effects of glycosaminoglycans with different degrees of sulphation. British Journal of Haematology. 71:265-269. 1989
- Aspirin and other platelet active drugs. Relationship among dose, effectiveness, and side effects. Chest. 95:12S-18. 1989
- HEMORRHAGIC COMPLICATIONS OF THROMBOLYTIC THERAPY IN THE TREATMENT OF MYOCARDIAL-INFARCTION AND VENOUS THROMBOEMBOLISM. Chest. 95:S88-S97. 1989
- Hemorrhagic Complications of Long-term Anticoagulant Therapy. Chest. 95:26S-36S. 1989
- Hemorrhagic Complications of Thrombolytic Therapy in the Treatment of Myocardial Infarction and Venous Thromboembolism. Chest. 95:88S-97S. 1989
- Hemorrhagic complications of long-term anticoagulant therapy.. Chest. 95:26S-36S. 1989
- Optimal Therapeutic Range for Oral Anticoagulants. Chest. 95:5S-11S. 1989
- Optimal therapeutic range for oral anticoagulants.. Chest. 95:5S-11S. 1989
- Use of Anticoagulants during Pregnancy. Chest. 95:156S-160S. 1989
- Use of anticoagulants during pregnancy.. Chest. 95:156S-160S. 1989
- An Evaluation of Impedance Plethysmography and 125I-Fibrinogen Leg Scanning in Patients following Hip Surgery. Thrombosis and Haemostasis. 62:830-834. 1989
- Laboratory monitoring of oral anticoagulant therapy.. Hematopathology and Molecular Hematology. 3:147-151. 1989
- NEW APPROACHES TO THE MANAGEMENT OF VENOUS THROMBOEMBOLISM - PROCEEDINGS OF A SATELLITE SYMPOSIUM HELD AT THE XTH INTERNATIONAL-CONGRESS ON THROMBOSIS ATHENS, GREECE, ON 22ND-27TH MAY, 1988 - INTRODUCTION. British Journal of Clinical Practice. 43:1-1. 1989
- Prevention of venous thrombosis in patients undergoing major orthopaedic surgical procedures.. International Journal of Clinical Practice, Supplement. 65:2-8. 1989
- Risks to the Fetus of Anticoagulant Therapy During Pregnancy. Thrombosis and Haemostasis. 61:197-203. 1989
- Risks to the Fetus of Radiologic Procedures Used in the Diagnosis of Maternal Venous Thromboembolic Disease. Thrombosis and Haemostasis. 61:189-196. 1989
- The Relationship between Anti-Factor Xa Level and Clinical Outcome in Patients Receiving Enoxaparine Low Molecular Weight Heparin to Prevent Deep Vein Thrombosis after Hip Replacement. Thrombosis and Haemostasis. 62:940-944. 1989
- Unfractionated heparin inhibits thrombin-catalysed amplification reactions of coagulation more efficiently than those catalysed by factor Xa. Biochemical Journal. 257:143-150. 1989
- Heparin clearance and ex vivo recovery in newborn piglets and adult pigs. Thrombosis Research. 52:517-527. 1988
- Optimum Use of Anticoagulants in Pregnancy. Drugs. 36:505-512. 1988
- Pseudothrombosis in pregnancy.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 139:409-410. 1988
- RANDOMISED COMPARISON OF TWO INTENSITIES OF ORAL ANTICOAGULANT THERAPY AFTER TISSUE HEART VALVE REPLACEMENT. The Lancet. 331:1242-1245. 1988
- International Committee Communications. Standardization and clinical use of LMW heparin. Report of the ICTH Heparin Subcommittee, Brussels, July 1987.. Thrombosis and Haemostasis. 59:333. 1988
- Pulmonary embolism in outpatients with pleuritic chest pain. JAMA Internal Medicine. 148:838-844. 1988
- Clinical utility of impedance plethysmography in the diagnosis of recurrent deep-vein thrombosis. JAMA Internal Medicine. 148:519-520. 1988
- The Thrombogenic Effect of Anticancer Drug Therapy in Women with Stage II Breast Cancer. New England Journal of Medicine. 318:404-407. 1988
- ALTERNATE METHODS OF HEPARIN ADMINISTRATION. Annals of Internal Medicine. 108:306-306. 1988
- An overview of clinical trials of low molecular weight heparin fractions.. British Journal of Surgery. 543:73-79. 1988
- Antithrombotic Properties of Heparin in a Neonatal Piglet Model of Thrombin-Induced Thrombosis. Thrombosis and Haemostasis. 60:289-292. 1988
- Clinical Use of Low Molecular Weight Heparins and Heparinoids. Seminars in Vascular Medicine. 14:116-125. 1988
- Confusion Over the Therapeutic Range for Monitoring Oral Anticoagulant Therapy in North America. Thrombosis and Haemostasis. 59:129-132. 1988
- Standardization and Clinical Use of LMW Heparin. Thrombosis and Haemostasis. 59:333-333. 1988
- The treatment of venous thromboembolism.. Nouvelle Revue Francaise d'Hematologie. 30:149-153. 1988
- Evolution of Thrombosis. Annals of the New York Academy of Sciences. 516:586-604. 1987
- The optimal intensity of oral anticoagulant therapy. Journal of the American Medical Association (JAMA). 258:2723-2726. 1987
- A Novel Whole Blood Capillary Technic for Measuring the Prothrombin Time. American Journal of Clinical Pathology. 88:442-446. 1987
- Adjusted Subcutaneous Heparin or Continuous Intravenous Heparin in Patients with Acute Deep Vein Thrombosis. ACP journal club. 107:441-441. 1987
- Evidence for a saturable mechanism of disappearance of standard heparin in rabbits. Thrombosis Research. 46:835-844. 1987
- The disappearance of a low molecular weight heparin fraction (cy 216) differs from standard heparin in rabbits. Thrombosis Research. 46:845-853. 1987
- HEPARIN FOR PROXIMAL-VEIN THROMBOSIS - REPLY. New England Journal of Medicine. 316:1162-1163. 1987
- Heparin for Proximal-Vein Thrombosis. New England Journal of Medicine. 316:1161-1163. 1987
- The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin. Biochemical Journal. 243:579-588. 1987
- Low-Molecular-Weight Heparin and Deep-Vein Thrombosis. New England Journal of Medicine. 316:949-949. 1987
- Is the dose of warfarin prescribed by American physicians unnecessarily high?. JAMA Internal Medicine. 147:769-771. 1987
- DOUBLE-BLIND RANDOMISED TRIAL OF ORG 10172 LOW-MOLECULAR-WEIGHT HEPARINOID IN PREVENTION OF DEEP-VEIN THROMBOSIS IN THROMBOTIC STROKE. The Lancet. 329:523-526. 1987
- TREATMENT OF PULMONARY EMBOLISM. Annual Review of Medicine. 38:91-105. 1987
- Catalysis of Thrombin Inhibition Provides an Index for Estimating the Antithrombotic Potential of Glycosaminoglycans in Rabbits. Thrombosis and Haemostasis. 57:286-293. 1987
- Sample Size in the Planning and Interpretation of Clinical Trials. Thrombosis and Haemostasis. 58:953-956. 1987
- The Basement Membrane Underlying the Vascular Endothelium Is Not Thrombogenic: In Vivo and In Vitro Studies with Rabbit and Human Tissue. Thrombosis and Haemostasis. 58:698-704. 1987
- Treatment of First Episode of Venous Thrombosis. Advances in Experimental Medicine and Biology. 214:187-193. 1987
- CLINICAL-FEATURES AND DIAGNOSIS OF VENOUS THROMBOSIS. Journal of the American College of Cardiology. 8:B114-B127. 1986
- Clinical features and diagnosis of venous thrombosis. Journal of the American College of Cardiology. 8:114B-127B. 1986
- Diagnosis of pulmonary embolism. Journal of the American College of Cardiology. 8:128B-136B. 1986
- EPIDEMIOLOGY AND PATHOGENESIS OF VENOUS THROMBOSIS. Journal of the American College of Cardiology. 8:B104-B113. 1986
- Epidemiology and pathogenesis of venous thrombosis. Journal of the American College of Cardiology. 8:104B-113B. 1986
- Mechanisms for Inhibition of the Generation of Thrombin Activity by Sulfated Polysaccharides^a. Annals of the New York Academy of Sciences. 485:41-55. 1986
- Therapeutic Range for the Control of Oral Anticoagulant Therapy. JAMA Neurology. 43:1162-1164. 1986
- Continuous Intravenous Heparin Compared with Intermittent Subcutaneous Heparin in the Initial Treatment of Proximal-Vein Thrombosis. New England Journal of Medicine. 315:1109-1114. 1986
- A Randomized Controlled Trial of a Low-Molecular-Weight Heparin (Enoxaparin) to Prevent Deep-Vein Thrombosis in Patients Undergoing Elective Hip Surgery. New England Journal of Medicine. 315:925-929. 1986
- ASPIRIN THERAPY FOR CORONARY-ARTERY DISEASE. Journal of the American Medical Association (JAMA). 256:1802-1802. 1986
- The haemorrhagic and antithrombotic effects of dermatan sulphate. British Journal of Haematology. 64:309-317. 1986
- The haemorrhagic and antithrombotic effects of dermatan sulphate.. British Journal of Haematology. 64:309-317. 1986
- Hemorrhagic doses of heparin and other glycosaminoglycans induce a platelet defect. Thrombosis Research. 43:491-495. 1986
- Introduction. Chest. 89:369S-369S. 1986
- Prophylaxis of Venous Thromboembolism. Chest. 89:374S-383S. 1986
- Prophylaxis of venous thromboembolism. An overview.. Chest. 89:374S-383S. 1986
- TREATMENT OF VENOUS THROMBOEMBOLISM. Chest. 89:S426-S433. 1986
- Treatment of Venous Thromboembolism. Chest. 89:426S-433S. 1986
- Venous Thromboembolism. Chest. 89:370S-373S. 1986
- Venous thromboembolism. Scope of the problem. Chest. 89:370S-373. 1986
- HEMORRHAGIC COMPLICATIONS OF LONG-TERM ANTICOAGULANT-THERAPY. Archives of Internal Medicine. 146:466-466. 1986
- THERAPEUTIC RANGE FOR ORAL ANTICOAGULANT-THERAPY. Archives of Internal Medicine. 146:466-466. 1986
- "Therapeutic range" for oral anticoagulant therapy.. Chest. 89:11S-15S. 1986
- Antithrombotic Agents in Coronary Artery Disease. Chest. 89:54S-67S. 1986
- Dose Antiplatelet Agents; The Relationship Among Side Effects, and Antithrombotic Effectiveness. Chest. 89:4S-10S. 1986
- Hemorrhagic Complications of Long-term Anticoagulant Therapy. Chest. 89:16S-25S. 1986
- Hemorrhagic complications of long-term anticoagulant therapy.. Chest. 89:16S-25S. 1986
- Management of anti-thrombin III deficiency during pregnancy without administration of anti-thrombin III. Thrombosis Research. 41:567-573. 1986
- Role of lipoxygenase metabolism in platelet function: Effect of aspirin and salicylate. Prostaglandins Leukotrienes and Medicine. 21:157-168. 1986
- “Therapeutic Range” for Oral Anticoagulant Therapy. Chest. 89:11S-15S. 1986
- A CRITICAL-APPRAISAL OF THE USE OF ANTICOAGULANT-THERAPY - EFFECTIVENESS, MONITORING, AND COMPLICATIONS - PREFACE. Seminars in Thrombosis and Hemostasis. 12:U1-U1. 1986
- A Low Molecular Weight Heparin Alters the Fetal Coagulation System in the Pregnant Sheep. Thrombosis and Haemostasis. 55:342-346. 1986
- Effect of Aspirin on Hemostasis and Thrombosis. New England and regional allergy proceedings. 7:26-31. 1986
- Effectiveness of Anticoagulants. Seminars in Vascular Medicine. 12:21-37. 1986
- Hemorrhagic Complications of Anticoagulant Therapy. Seminars in Vascular Medicine. 12:39-57. 1986
- Hemorrhagic complications of long-term anticoagulant therapy for ischemic cerebral vascular disease.. Stroke. 17:111-116. 1986
- INVIVO EFFECTS OF LOW-MOLECULAR-WEIGHT HEPARINS ON EXPERIMENTAL THROMBOSIS AND BLEEDING. Pathophysiology of Haemostasis and Thrombosis: international journal on haemostasis and thrombosis research. 16:82-86. 1986
- In vivo Effects of Low Molecular Weight Heparins on Experimental Thrombosis and Bleeding. Pathophysiology of Haemostasis and Thrombosis: international journal on haemostasis and thrombosis research. 16:82-86. 1986
- Mechanism of Action and Monitoring of Anticoagulants. Seminars in Vascular Medicine. 12:1-11. 1986
- Diagnostic Value of Ventilation-Perfusion Lung Scanning in Patients with Suspected Pulmonary Embolism. Chest. 88:819-828. 1985
- The thrombolytic and hemorrhagic effects of tissue type plasminogen activator: Influence of dosage regimens in rabrits. Thrombosis Research. 40:769-777. 1985
- Risk of Haemorrhage Associated with Long Term Anticoagulant Therapy. Drugs. 30:444-460. 1985
- Effects of heparin, its low molecular weight fractions and other glycosaminoglycans on thrombus growth. Thrombosis Research. 40:81-89. 1985
- Recurrent leg symptoms following deep vein thrombosis. A diagnostic challenge. JAMA Internal Medicine. 145:1867-1869. 1985
- The optimal antithrombotic dose of aspirin. JAMA Internal Medicine. 145:1582-1583. 1985
- Sustained thrombolysis with DNA-recombinant tissue type plasminogen activator in rabbits. Blood. 66:399-401. 1985
- The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate. British Journal of Haematology. 60:695-704. 1985
- A comparison of the thrombolytic and hemorrhagic effects of tissue-type plasminogen activator and streptokinase in rabbits.. Circulation. 72:178-182. 1985
- An evaluation of suloctidil in the prevention of deep vein thrombosis in neurosurgical patients. Thrombosis Research. 39:173-181. 1985
- ADVANCES AND CONTROVERSIES IN THE DIAGNOSIS, PREVENTION AND THERAPY OF DEEP VENOUS THROMBOSIS - THERAPY AND PROPHYLAXIS .2.. Medicina (Florence, Italy). 5:143-164. 1985
- ADVANCES AND CONTROVERSIES IN THE DIAGNOSIS, PREVENTION AND THERAPY OF DEEP VENOUS THROMBOSIS .1. THE DIAGNOSIS. Medicina (Florence, Italy). 5:1-16. 1985
- Diagnostic Efficacy of Impedance Plethysmography for Clinically Suspected Deep-Vein Thrombosis. ACP journal club. 102:21-21. 1985
- Endothelial Cells Produce a Lipoxygenase Derived Chemo-Repellent which Influences Platelet/Endothelial Cell Interactions – Effect of Aspirin and Salicylate. Thrombosis and Haemostasis. 53:306-311. 1985
- In vivo activity of a new heparinoid. Pathology. 17:78-81. 1985
- In vivo activity of a new heparinoid.. Pathology. 17:78-81. 1985
- Placental transport of low molecular weight heparin in the pregnant sheep. British Journal of Haematology. 59:103-108. 1985
- Progress review: the relationship between dose of aspirin, side-effects and antithrombotic effectiveness.. Stroke. 16:1-4. 1985
- Rationale Behind the Development of Low Molecular Weight Heparin Derivatives. Seminars in Vascular Medicine. 11:13-16. 1985
- THE RELATIONSHIP BETWEEN DOSE OF ASPIRIN, SIDE-EFFECTS AND ANTITHROMBOTIC EFFECTIVENESS. Stroke. 16:1-4. 1985
- The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparin. Blood. 65:198-201. 1985
- Outcome of abnormal impedance plethysmography results in patients with proximal-vein thrombosis: Frequency of return to normal. Thrombosis Research. 36:259-263. 1984
- Effects of heparin fractions of different affinities to antithrombin III and thrombin on the inactivation of thrombin and factor Xa by antithrombin III. Biochemistry and Cell Biology. 62:975-983. 1984
- LIDOCAINE AND THE REDUCTION OF POST‐VENOGRAPHIC PAIN. Internal Medicine Journal. 14:622-625. 1984
- A comparison of the anti thrombotic and haemorrhagic effects of low molecular weight heparin fractions: The influence of the method of preparation. Thrombosis Research. 35:613-625. 1984
- Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways. Blood. 64:742-747. 1984
- Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways.. Blood. 64:742-747. 1984
- The Diagnosis of Clinically Suspected Venous Thrombosis. Clinics in Chest Medicine. 5:439-456. 1984
- Heparin Side Effects—Reply. JAMA Internal Medicine. 144:1693-1693. 1984
- A cost-effectiveness analysis of alternative approaches for long-term treatment of proximal venous thrombosis. Journal of the American Medical Association (JAMA). 252:235-239. 1984
- Effect of aspirin and salicylate on platelet-vessel wall interactions in rabbits.. Arteriosclerosis. 4:403-406. 1984
- New Approaches for Deep Vein Thrombosis Occurring After Surgery. Journal of the American Medical Association (JAMA). 251:2985-2985. 1984
- The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor. British Journal of Haematology. 57:229-238. 1984
- Heparin induced bleeding.. Nouvelle Revue Francaise d'Hematologie. 26:261-266. 1984
- PREVENTING VENOUS THROMBOEMBOLISM. Journal of Cardiovascular Medicine. 9:63-&. 1984
- PROPHYLAXIS OF VENOUS THROMBOEMBOLISM. Modern concepts of cardiovascular disease. 53:25-29. 1984
- Factors XI and XII are low in subjects with liver disease. Digestive Diseases and Sciences. 28:967-970. 1983
- Long-term anticoagulant therapy in patients with venous thrombosis. JAMA Internal Medicine. 143:2061-2063. 1983
- The pharmacokinetics and bioavailability of subcutaneously administered dihydroergotamine, heparin and the dihydroergotamine-heparin combination. Thrombosis Research. 31:51-67. 1983
- Pulmonary Angiography, Ventilation Lung Scanning, and Venography for Clinically Suspected Pulmonary Embolism with Abnormal Perfusion Lung Scan. ACP journal club. 98:891-891. 1983
- The sex-related differences in aspirin pharmacokinetics in rabbits and man and its relationship to antiplatelet effects. Thrombosis Research. 29:125-139. 1983
- Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein Thrombosis. New England Journal of Medicine. 307:1676-1681. 1982
- Cost-effectiveness of primary and secondary prevention of fatal pulmonary embolism in high-risk surgical patients.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 127:990-995. 1982
- Discordance between the anti-Xa activity and the antithrombotic activity of an ultra-low molecular weight heparin fraction. Thrombosis Research. 28:401-409. 1982
- Heparin with low affinity to antithrombin III inhibits the activation of prothrombin in normal plasma. Thrombosis Research. 28:487-497. 1982
- Inhibition of arterial thrombosis and platelet function by nafazatrom. Thrombosis Research. 28:157-170. 1982
- Comparison of the in vivo hemorrhagic and antithrombotic effects of a low antithrombin-iii affinity heparin fraction. Thrombosis Research. 27:679-690. 1982
- Adjusted Subcutaneous Heparin versus Warfarin Sodium in the Long-term Treatment of Venous Thrombosis. Obstetrical and Gynecological Survey. 37:492-493. 1982
- Subcutaneous Heparin for Venous Thrombosis. New England Journal of Medicine. 307:56-58. 1982
- The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits. Blood. 59:1239-1245. 1982
- ANTIPLATELET AGENTS: THEIR ROLE IN THE PREVENTION OF SUDDEN DEATH. Annals of the New York Academy of Sciences. 382:289-304. 1982
- Aspirin inhibits platelet function independent of the acetylation of ciclo-oxygenase. Thrombosis Research. 25:363-373. 1982
- Sex related differences in platelet function: the effect of aspirin. Blood. 59:625-627. 1982
- The diagnostic value of the fibrinogen/fibrin fragment E antigen assay in clinically suspected deep vein thrombosis. Blood. 59:346-350. 1982
- Adjusted Subcutaneous Heparin versus Warfarin Sodium in the Long-Term Treatment of Venous Thrombosis. New England Journal of Medicine. 306:189-194. 1982
- ASPIRIN INHIBITS PLATELET-FUNCTION INDEPENDENT OF THE ACETYLATION OF CYCLO-OXYGENASE. Thrombosis Research. 25:263-373. 1982
- Increased Platelet Destruction. Seminars in Vascular Medicine. 8:75-82. 1982
- SUBCUTANEOUS HEPARIN FOR VENOUS THROMBOSIS - REPLY. New England Journal of Medicine. 307:57-58. 1982
- Sex-related differences in the efficacy of acetylsalicylic acid (ASA): The absorption of ASA and its effect on collagen-induced thromboxane B2 generation. Thrombosis Research. 24:163-168. 1981
- Clinical validity of a negative venogram in patients with clinically suspected venous thrombosis.. Circulation. 64:622-625. 1981
- Drug-induced thrombocytopenia is associated with increased binding of IgG to platelets both in vivo and in vitro. Blood. 58:524-529. 1981
- Activation of factor X and prothrombin in antithrombin-III depleted plasma: The effects of heparin. Thrombosis Research. 23:331-345. 1981
- Prevention of deep venous thrombosis.. British journal of hospital medicine (London, England : 2005). 26:143-147. 1981
- The development and application of a serum assay for platelet-bindable IgG (S-PBIgG).. Translational Research. 98:272-279. 1981
- Cost Effectiveness of Clinical Diagnosis, Venography, and Noninvasive Testing in Patients with Symptomatic Deep-Vein Thrombosis. New England Journal of Medicine. 304:1561-1567. 1981
- The reversible binding of vinblastine to platelets: implications for therapy. Blood. 57:431-438. 1981
- Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction. JAMA Internal Medicine. 141:311-315. 1981
- The low specificity of postoperative perfusion lung scan defects.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 124:153-158. 1981
- Advances and controversies in the diagnosis, prevention, and treatment of venous thromboembolism.. Progress in hematology. 12:73-123. 1981
- Blood tests for the diagnosis of venous and arterial thrombosis. Blood. 57:1-8. 1981
- CHOOSING THE BEST OF OLD AND NEW WAYS TO PREVENT VENOUS THROMBOSIS. Journal of Cardiovascular Medicine. 6:691-&. 1981
- Practical Application of¹²⁵I-Fibrinogen Leg Scanning. Critical Reviews in Clinical Laboratory Sciences. 14:241-255. 1981
- Relationship between the antithrombotic and anticoagulant effects of low molecular weight heparin. Thrombosis Research. 21:169-174. 1981
- Replacement of Venography in Suspected Venous Thrombosis by Impedance Plethysmography and¹²⁵I-Fibrinogen Leg Scanning. ACP journal club. 94:12-12. 1981
- The factor VIII-independent activation of factor X by factors IXa and VII in plasma. Thrombosis Research. 21:23-33. 1981
- [Prevention of deep vein thrombosis and pulmonary thromboembolism].. Medicina. 41:485-498. 1981
- Differences in inhibition of PGI2 production by aspirin in rabbit artery and vein segments. Thrombosis Research. 20:447-460. 1980
- The inhibition by heparin of the intrinsic pathway activation of factor X in the absence of antithrombin-III. Thrombosis Research. 20:391-403. 1980
- Bleeding associated with antithrombotic therapy.. Seminars in Hematology. 17:259-291. 1980
- Immunodepletion of human plasma factor VIII. Blood. 56:604-607. 1980
- Preparation and partial characterization of human plasma depleted of antithrombin-III by heparin-sepharose affinity chromatography. Thrombosis Research. 20:77-83. 1980
- Sex-related differences in platelet aggregation: influence of the hematocrit. Blood. 56:38-41. 1980
- Thrombocytopenia in septicemia: the role of disseminated intravascular coagulation. Blood. 56:88-92. 1980
- A comparison of the quantitative ristocetin von willebrand factor assay by using fresh and fixed platelets. Thrombosis Research. 18:477-483. 1980
- Prevention of Recurrent Venous Thrombosis: Warfarin versus Heparin. New England Journal of Medicine. 302:752-753. 1980
- Simplification of the sequential impedance plethysmograph technique without loss of accuracy. Thrombosis Research. 17:561-565. 1980
- DIAGNOSIS OF DEEP-VEIN THROMBOSIS BY INVASIVE AND NON INVASIVE METHODS. Medicina. 40:708-717. 1980
- PREVENTION OF RECURRENT VENOUS THROMBOSIS - WARFARIN VERSUS HEPARIN - REPLY. New England Journal of Medicine. 302:753-753. 1980
- Sex-related differences in platelet function in vivo following aspirin administration. Circulation. 62. 1980
- The inhibitory effect of aspirin platelet function independent of acetylation of cyclo oxygenase. Circulation. 62. 1980
- The relationship between the hemorrhagic and antithrombotic effects of standard and low molecular weight (LMW) heparins. Circulation. 62. 1980
- [Diagnosis of deep vein thrombosis by invasive and non invasive methods].. Medicina. 40:708-717. 1980
- Decreased platelet thrombogenecity in association with increased platelet turnover and vascular damage. Blood. 54:1369-1375. 1979
- Shortening of the bleeding time in thrombocytopenic rabbits after exposure of jugular vein to high aspirin concentration. Prostaglandins Leukotrienes and Essential Fatty Acids. 3:333-342. 1979
- Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous Thrombosis. New England Journal of Medicine. 301:855-858. 1979
- Antiplatelet drugs in thromboembolism. Postgraduate Medicine. 66:119-127. 1979
- Leprosy's Footprints in Bone Marrow. New England Journal of Medicine. 301:272-273. 1979
- Platelet-Associated IgG in Septicemia. New England Journal of Medicine. 301:271-272. 1979
- Thrombocytopenia found uncommonly during heparin therapy. Journal of the American Medical Association (JAMA). 241:2396-2397. 1979
- When and how to use heparin prophylaxis and treatment.. Geriatrics: better medicine for midlife and beyond. 34:59-70. 1979
- Shortening of the Bleeding Time in Rabbits by Hydrocortisone Caused by Inhibition of Prostacyclin Generation by the Vessel Wall. Journal of Clinical Investigation. 63:1026-1035. 1979
- Elevated Platelet-Associated IgG in the Thrombocytopenia of Septicemia. New England Journal of Medicine. 300:760-764. 1979
- Comparison of the haemorrhagic effects of porcine and bovine heparin in rabbits. Thrombosis Research. 15:581-586. 1979
- Definition of High Risk/High Response Population for Stroke in Patients with Transient Ischemic Attacks. Thrombosis and Haemostasis. 41:43-57. 1979
- Effectiveness of intermittent pulsatile elastic stockings for the prevention of calf and thigh vein thrombosis in patienis undergoing elective knee surgery. Thrombosis Research. 16:37-45. 1979
- Heparin. Nova Scotia Medical Bulletin. 58:25-29. 1979
- Increased dipyridamole plasma concentrations associated with salicylate administration. Relationship to effects on platelet aggregation in vivo. Thrombosis Research. 15:813-820. 1979
- International Committee Communications. Thrombosis and Haemostasis. 41:450-453. 1979
- Prevention of venous thrombosis by intermittent sequential calf compression in patients with intracranial disease. Thrombosis Research. 15:611-616. 1979
- Prolonged Inhibition of PGI2 Production and Associatedincreased Thrombogenic Effect in Arteries After Aspirin Administration. Thrombosis and Haemostasis. 42:61-61. 1979
- Prophylaxis and Therapy of Venous Thromboembolism. Critical Reviews in Clinical Laboratory Sciences. 10:247-274. 1979
- The direct assay for platelet-associated IgG (PAIgG): lack of association between antibody level and platelet size. Blood. 53:73-80. 1979
- The value of adding impedance plethysmography to 125I-fibrinogen leg scanning for the detection of deep vein thrombosis in high risk surgical patients: A comparative study between patients undergoing general surgery and hip surgery. Thrombosis Research. 15:227-234. 1979
- Uncontrolled PGI2 production by whole vessel wall segments due to thrombin generation and its prevention by heparin. Thrombosis Research. 16:551-555. 1979
- Impedance plethysmography: the relationship between venous filling and sensitivity and specificity for proximal vein thrombosis.. Circulation. 58:898-902. 1978
- Sex differences in the antithrombotic effects of aspirin. Blood. 52:1073-1076. 1978
- The prolonged effect of sulfinpyrazone on collagen-induced platelet aggregation in vivo. Thrombosis Research. 13:883-892. 1978
- Thrombogenic Effect of High-Dose Aspirin in Rabbits. Journal of Clinical Investigation. 62:892-895. 1978
- A comparison of the effects of aspirin and dipyridamole on platelet aggregation in vivo and ex vivo. Thrombosis Research. 13:517-529. 1978
- Plasma fibrinopeptide A levels in symptomatic venous thromboembolism. Blood. 51:1189-1195. 1978
- PLATELET SUPPRESSIVE THERAPY. British Medical Bulletin. 34:183-190. 1978
- Determination of sulphinpyrazone in patient plasma by gas chromatography. Thrombosis Research. 12:247-255. 1978
- [Anticoagulants and other drugs effective against thrombosis].. L'union medicale du Canada. 107:179-184. 1978
- [Diagnosis of venous thrombo--emboli].. L'union medicale du Canada. 107:204-217. 1978
- [Treatment of venous thrombo--emboli].. L'union medicale du Canada. 107:232-237. 1978
- [Venous thromboemboli].. L'union medicale du Canada. 107:238-241. 1978
- ANTICOAGULANT THERAPY AND RECURRENT VENOUS-THROMBOSIS. Journal of the American Medical Association (JAMA). 240:284-284. 1978
- ANTICOAGULANTS AND OTHER DRUGS IN THROMBOSIS. L'union medicale du Canada. 107:179-184. 1978
- CLINICAL DIAGNOSIS OF VENOUS THROMBO EMBOLISMS. L'union medicale du Canada. 107:204-&. 1978
- Comparative effects of sodium and calcium heparin on plasma heparin concentration, partial thromboplastin time, platelet count and bleeding. Circulation. 58. 1978
- Comparative value of tests for the diagnosis of venous thrombosis. World Journal of Surgery. 2:27-34. 1978
- Platelet inhibitors in the treatment of thrombosis.. Clinical and Investigative Medicine. 1:191-206. 1978
- Hypercoagulability.. Seminars in Hematology. 14:409-425. 1977
- Increased heparin clearance in experimental pulmonary embolism.. Translational Research. 90:204-215. 1977
- Combined Use of Leg Scanning and Impedance Plethysmography in Suspected Venous Thrombosis. New England Journal of Medicine. 296:1497-1500. 1977
- Prevention of venous thrombosis in patients with intracranial disease by intermittent pneumatic compression of the calf. Neurology. 27:435-435. 1977
- Relationship between the anticoagulant and antithrombotic effects of heparin in experimental venous thrombosis. Blood. 49:171-184. 1977
- Assessment of antithrombotic drugs ex vivo and in vivo.. Bibliotheca anatomica. 208-211. 1977
- Theoretical and Practical Aspects of Thrombolytic Therapy. Angiology. 28:1-6. 1977
- Low dose heparin prophylaxis.. Canadian Family Physician. 22:47-50. 1976
- Thrombotic thrombocytopenic purpura: a syndrome of intravascular platelet consumption.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 114:1108-1112. 1976
- Prevention of venous thrombosis with small, subcutaneous doses of heparin. Journal of the American Medical Association (JAMA). 235:1980-1982. 1976
- The effect of experimental hematoma on serum levels of fibrinogen- related antigen. Blood. 47:855-859. 1976
- Diagnosis of Venous Thromboembolism. Seminars in Vascular Medicine. 2:203-231. 1976
- Heparin kinetics in venous thrombosis and pulmonary embolism.. Circulation. 53:691-695. 1976
- Impedance plethysmography using the occlusive cuff technique in the diagnosis of venous thrombosis.. Circulation. 53:696-700. 1976
- Prevention of Venous Thromboembolism. Seminars in Vascular Medicine. 2:232-290. 1976
- Treatment of venous thromboembolic disease.. Seminars in Vascular Medicine. 2:291-331. 1976
- Antithrombotic Drugs. Drugs. 12:41-68. 1976
- Antithrombotic Drugs. Drugs. 12:132-157. 1976
- In Vitro and in Vivo Functions of Thrombin-Treated Platelets \textbar Request PDF. Thrombosis and Haemostasis. 35:151-166. 1976
- Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease. New England Journal of Medicine. 293:1296-1300. 1975
- Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease. New England Journal of Medicine. 293:1236-1240. 1975
- Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease. New England Journal of Medicine. 293:1174-1178. 1975
- Proceedings: Comparison of in vivo and in vitro effects of platelet function suppressing drugs.. Thrombosis and Haemostasis. 34:552. 1975
- Proceedings: Efficacy and monitoring of heparin therapy in experimental venous thrombosis.. Thrombosis and Haemostasis. 34:597. 1975
- Proceedings: Heparin kinetics in venous thrombosis and pulmonary embolism.. Thrombosis and Haemostasis. 34:598. 1975
- Proceedings: Platelet survival, fibrinolytic activity, antithrombin II (AT III) level and fibrinogen survival in venous thromboembolism (VTE).. Thrombosis and Haemostasis. 34:566. 1975
- 125-I-labeled fibrinogen scanning. Use in the diagnosis of venous thrombosis. Journal of the American Medical Association (JAMA). 233:970-973. 1975
- The role of sulfinpyrazone in the prevention of arterio-venous shunt thrombosis.. Circulation. 52:497-499. 1975
- Mechanisms for elevated fibrin/fibrinogen degradation products in acute experimental pulmonary embolism. Blood. 45:563-568. 1975
- Observations in anticoagulant and thrombolytic therapy in pulmonary embolism. Progress in Cardiovascular Diseases. 17:335-343. 1975
- Critical evaluation of platelet-inhibiting drugs in thrombotic disease.. Progress in hematology. 9:229-254. 1975
- The Current Status of Platelet Suppressive Drugs in the Treatment of Thrombosis. Thrombosis and Haemostasis. 33:406-416. 1975
- Resolution of Experimental Pulmonary Emboli with Heparin and Streptokinase in Different Dosage Regimens. Journal of Clinical Investigation. 54:782-791. 1974
- Diagnosis of thrombosis. Evaluation of 125I-fibrinogen scanning and blood tests.. Thrombosis and Haemostasis. 32:11-20. 1974
- Effects of sodium warfarin administered during pregnancy in mice. American Journal of Obstetrics and Gynecology. 118:819-823. 1974
- Investigation of the Mechanism of False Positive ¹²⁵I‐Labelled Fibrinogen Scans. British Journal of Haematology. 26:469-473. 1974
- TUMORS, MUCUS PRODUCTION, AND HYPERCOAGULABILITY. Annals of the New York Academy of Sciences. 230:262-270. 1974
- Arteriovenous-Shunt Thrombosis. New England Journal of Medicine. 290:304-306. 1974
- Anticoagulants in Venous Thromboembolism. Postgraduate Medicine. 55:211-217. 1974
- RELEVANCE OF PREOPERATIVE AND POSTOPERATIVE BLOOD TESTS TO POSTOPERATIVE LEG-VEIN THROMBOSIS. The Lancet. 302:805-809. 1973
- Von Willebrand's Syndrome Presenting as an Acquired Bleeding Disorder in Association With a Monoclonal Gammopathy. Blood. 42:429-436. 1973
- Prolonged Prothrombin Time and Partial Thromboplastin Time in Disseminated Intravascular Coagulation not Due to Deficiency of Factors V and VIII. British Journal of Haematology. 24:725-734. 1973
- Small Subcutaneous Doses of Heparin in Prevention of Venous Thrombosis. New England Journal of Medicine. 288:545-551. 1973
- Relation Between Bleeding Time and Platelet Connective Tissue Reaction After Aspirin. Blood. 41:369-377. 1973
- Platelets.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 108:416-passim. 1973
- AUSTRALIAN MULTICENTRE TRIAL OF STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION. The Lancet. 301:57-60. 1973
- Preparation of human fibrinogen free of plasminogen by immunoadsorption. Pathophysiology of Haemostasis and Thrombosis: international journal on haemostasis and thrombosis research. 1:210-214. 1973
- The diagnosis and prevention of post operative venous thrombosis.. Supplementum . ad Thrombosis and haemostasis. 56:145-155. 1973
- The value of monitoring heparin therapy in the prevention of recurrence in patients with venous thromboembolic disease.. Supplementum . ad Thrombosis and haemostasis. 56:181-190. 1973
- A Prospective Study of the Value of Monitoring Heparin Treatment with the Activated Partial Thromboplastin Time. New England Journal of Medicine. 287:324-327. 1972
- The influence of drugs upon the anticoagulant activity of heparin.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 106:562-564. 1972
- Anticoagulants in pregnancy: A review of indications and complications. American Heart Journal. 83:301-305. 1972
- Early rate of resolution of major pulmonary embolism. A study of angiographic and haemodynamic changes occurring in the first 24 to 48 hours.. Heart. 33:432-437. 1971
- Thrombolytic Therapy and Fatal Pulmonary Emboli. ACP journal club. 75:140-140. 1971
- Divergent effects of aspirin and salicylate on glucose and glycogen metabolism in human platelets. Cellular and Molecular Life Sciences. 27:533-534. 1971
- Comparison of the effects of streptokinase and heparin on the early rate of resolution of major pulmonary embolism.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 104:488-91 passim. 1971
- Effect of streptokinase therapy on experimental fibrin-rich arterial thrombi.. American Journal of Pathology. 62:7-16. 1971
- Fetal Effects of Coumadin Administered During Pregnancy. Blood. 36:623-627. 1970
- The Activated Partial Thromboplastin Time in the Control of Heparin Treatment. Internal Medicine Journal. 19:334-337. 1970
- ANTICOAGULANTS AFTER OPEN‐HEART SURGERY. Medical Journal of Australia. 2:5-6. 1970
- Clinical Experience with Anticoagulant Therapy During Pregnancy. The BMJ. 1:270-273. 1970
- Dosage Regimens for Streptokinase Treatment: Evaluation of a Standard Dosage Schedule. Internal Medicine Journal. 19:12-16. 1970
- EVALUATION OF SUBCUTANEOUS CALCIUM HEPARIN THERAPY IN THE TREATMENT OF THROMBO‐EMBOLIC DISEASE. Medical Journal of Australia. 1:15-17. 1970
- Streptokinase in the Treatment of Major Pulmonary Embolism—Experience with Twenty‐five Patients. Internal Medicine Journal. 19:54-59. 1970
- ARTERIAL THROMBOSIS IN A PATIENT WITH CHRONIC THROMBOCYTOPENIA SUCCESSFUL TREATMENT WITH INTRAARTERIAL INFUSION OF STREPTOKINASE. Medical Journal of Australia. 2:1304-1306. 1969
- Aspirin: Its Effect on Platelet Glycolysis and Release of Adenosine Diphosphate. Science. 165:65-67. 1969
- Placental Barrier to Coagulation Factors: Its Relevance to the Coagulation Defect at Birth and to Haemorrhage in the Newborn. The BMJ. 2:281-283. 1969
- Streptokinase in acute major pulmonary embolism.. Israel Medical Association Journal. 5:844-848. 1969
- Streptokinase Therapy in Acute Major Pulmonary Embolism: Effectiveness and Problems. The BMJ. 4:729-734. 1968
- Effect of Streptokinase on Hemostasis. Blood. 32:726-737. 1968
- Effect of activation of the fibrinolytic mechanism on experimental platelet-rich thrombi in rabbits.. Translational Research. 72:245-255. 1968
- Aspirin: its effect on platelet glycolysis and release of adenosine diphosphate.. Science. 165:65-67. 1968
- HEPARIN IN THE TREATMENT OF VENOUS THROMBOEMBOLIC DISEASE: ADMINISTRATION, CONTROL AND RESULTS. Medical Journal of Australia. 2:153-159. 1968
- The effect of platelet age on platelet adherence to collagen. Journal of Clinical Investigation. 47:466-473. 1968
- RESOLUTION OF ACUTE MASSIVE PULMONARY EMBOLISM AFTER PULMONARY ARTERIAL INFUSION OF STREPTOKINASE. The Lancet. 290:593-597. 1967
- Increased platelet adhesiveness in recurrent venous thrombosis and pulmonary embolism.. The BMJ. 2:797-799. 1965
- THE DEVELOPMENT OF UROKINASE AS A THROMBOLYTIC AGENT. MAINTENANCE OF A SUSTAINED THROMBOLYTIC STATE IN MAN BY ITS INTRAVENOUS INFUSION.. Translational Research. 65:713-731. 1965